Transfer factor

Transfer factor (TF) is an extract of low molecular weight containing several lymphokine molecules with immunomodulating properties. It has been described for the first time by Lawrence in the early ‘50s. It seems capable of transferring antigen-specific information to T-lymphocytes, and it is present in the lymphocytes of mammals and birds. It has been widely used over the past forty years in the treatment of viral, parasitic, fungal infections and allergic disorders, as well as immunodeficiencies, neoplasias, viz. cancer of the lung and prostate. Encouraging clinical results have also been observed in patients suffering from candidiasis and tuberculosis.

It has been thought that the potential of this compound for answering the challenge of unknown pathogenic agents is considerable as is its preventative potential. Data have shown that antigen-specific TF administered before a viral infection can prevent the onset of the disease, TF acting as a preventative vaccine based on cell mediated immunity.

Its molecular structure has only partially been unravelled. It seems that to a small peptide (ca. 5000 DA) are attached 2-3 ribonucleotides. However, this lack of knowledge did not prevent its clinical use since it is possible to produce large quantities of specific transfer factor in tissue culture or in immunised animals.

See also

• Lymphokine

---

History, properties and therapeutic effects

The first observations postulating the existence and establishing the concept of transfer factor dates from the early 1950s when H.S. Lawrence showed that delayed type hypersensitivity (DTH) to a given antigen could be transferred from one individual to another via cell-free extracts obtained from the leucocytes of an immunised donor. He assumed that this adoptive transfer of immunity was due to a molecule which he named transfer factor and he surmised that its molecular weight was less than 12,000 Daltons, as it filters through a standard dialysis bag. Since that time, all transfer factor preparations for clinical and experimental studies have been obtained by disrupting lymphocytes, dialysing the lysates and using the dialysed material for in vitro tests or in vivo clinical or animal studies.

Over fifteen hundred reports have confirmed Lawrence’s original observations and established that the dialyzable extracts thus obtained are capable of transferring specific immune information in vitro to naïve lymphocytes or in vivo to patients or experimental animals. This information concerns only cell-mediated but not humoral immunity, no de novo antibody production has ever been elicited by transfer factor, although it has been reported that it may modulate normal antibody production triggered by conventional immunisation.

Since the early 70’s, transfer factor has been used more often than not successfully for the treatment of viral, parasitic, fungal infections, and also as an adjuvant treatment in autoimmune, allergic and malignant disorders. Its apparent success is of no surprise since cell-mediated immunity (CMI) plays a crucial role in the control of infectious, parasitic, and autoimmune diseases, as well as cancer.

Because the TF extract is usually obtained from the total lymphocyte population containing helper and suppressor lymphocytes, it acts as a modulator of the immune system. It boosts the immune defences when required, e.g. in infectious, malignant or genetically impaired immune disorders or it exerts a suppressing effect on a hyperactive immune system when its down-regulation is desirable, e.g. in allergic disorders.

The mechanism of action of TF remains largely unknown, its activity, in addition to the transfer of immune information, is manifested as a non-specific modulation of the immune response. It is known that the dialyzable extract containing the TF molecules also contains other low molecular weight lymphokines e.g. IMREG 1 and 2. Thus, its non-antigen-specific immunomodulating activity, which may also play a role in the regulation of humoral immunity, is due to molecules present in the dialysate, but distinct from those responsible for the transfer of antigen-specific information.

It seems that the total dialysate obtained from peripheral lymphocytes is a cocktail of molecules that provide immunoregulatory activity, in addition to the adoptive transfer of novel antigenic specificities to the immunological memory of the recipient. Hence the qualification of TF as an immunomodulator, i.e. a lymphokine with immunomodulatory activity mediating adoptive immunity, in contrast with so-called active (antibody induction by immunisation with the corresponding antigen) or passive (mediated by antibody injection) immunity.

Nonetheless, and notwithstanding encouraging clinical results, many drawbacks have impeded research in this field and fast advances in understanding the nature and mode of action of this intriguing biological entity.

Until 1974, the only source of transfer factor was pooled leucocytes from blood donors, which limited material supplies, whereas the biological potency and specific activity of the extract varied from one preparation to another. Indeed, the precise antigenic specificity of the various batches of material used was practically unknown, but presumably large, since each batch reflected the collective immune experience of several individuals. For this reason, these preparations were improperly called “non-specific”, indicating multiple but unknown specificities.

Thus, despite several encouraging reports in the early 1970s, the clinical use of transfer factor was curtailed by the dearth of material with standardised and consistent activity. Similarly, biochemical studies were virtually impossible for lack of sufficient raw material for purification. In 1974, Viza and co-workers reported that TF with known specificities could be replicated in tissue culture, using a lymphoblastoid cell line. In the late 1970s, the same group and other investigators presented evidence that specific TF obtained from mammals after immunisation with a given antigen was also active in humans.

Nevertheless, in spite of the resolution of the supply problem, the controversy relating to this molecule was to grow. There are several reasons for this, and they pertain mainly to its unusual characteristics.

Nearly fifty years after Lawrence’s original observations, transfer factor remains an elusive and controversial entity, despite enormous laboratory efforts and several clinical studies with encouraging and sometimes spectacular results. Biochemical studies have already produced evidence that the molecule responsible for the transfer of the antigenic specificity is a small peptide with a molecular weight of approximately 5000 DA, and it has been suggested that two to three ribonucleotides are attached to the peptide. Unfortunately, attempts at sequencing the peptide have failed, because of the presence of a blocked amino terminus.

The transfer of antigen-specific CMI information by this extract is thought provoking, for it apparently contravenes essential tenets of immunology and molecular biology. However, since the experimental evidence supporting the antigen-specific transfer is uncontested, various hypotheses for understanding its mechanism have been proposed, but so far none has proven totally acceptable.

The specificity issue thus remains one of the essential problems. TF dialysates contain non-specific immunoregulatory molecules which can usually enhance and, in certain cases, down-regulate CMI. Two such molecules named IMREG I and IMREG II were identified by Gottlieb and his co-workers. Nevertheless, such moieties could play a role in enhancing a weak response to a ubiquitous antigen and thus provide false evidence of specific transfer. Studies undertaken with such rare antigens as coccidioidin or keyhole limpet haemocyanin (KLH) preclude non-specific enhancement of “lapsed” immunological memory. Several human and animal studies have established that TF is capable of transferring CMI to rare antigens that the recipient is unlikely to have encountered by chance.

The overall picture became more complex when two types of antigen-specific activity were described within the dialysates: a) inducer or helper activity, which is the activity of the conventional transfer factor and b) anti-transfer factor or suppressor activity. The distinctive properties of the two entities are as follows: transfer factor binds to its related antigen, suppressor factor binds to the related antibody (IgG); inducer factor is absorbed by T suppressor cells and macrophages, whereas suppressor factor is absorbed by T-helper cells and macrophages; inducer factor derives from T-helper cells, suppressor factor from T-suppressor cells.

Be that as it may, TF’s characteristics (low molecular weight, undefined chemical structure, unconventional mode of action, protein-like nature but resistant to most proteolytic enzymes) together with its biological properties (non-species specificity, transfer of antigen-specific information) have generated more opponents than supporters. And the frustration resulting from unsuccessful attempts to solve this multi-faceted riddle, especially the failure so far to unravel the molecular structure, apparently due to a blocked amino terminus of the peptide forbidding its sequence by conventional methods, has led scientists to doubt its very existence.

Despite promising results and hundreds of publications, failure to explain TF’s mechanism of action and define its molecular structure aroused doubts about its very existence. And even though recent work by Kirkpatrick has partially determined an amino-acid sequence (LLYAQDLEDN), thus giving some biochemical reality to the elusive moiety, no further publication has confirmed and complemented these data since.

Moreover, the pharmaceutical industry did not pay sufficient attention to this moiety because of the prohibitive costs of bringing a new medicine onto the market and the lack of patent protection (the impossibility of filing patents after decades of published academic work). In addition, the difficulties involved in production made commercialisation unviable. And a compound producing such astounding results as those described in scientific literature, which has not been on the market for so many years, gradually begins to lose its credibility. As for the commercial preparations obtained from colostrums and today available via the internet they scarcely increased the credibility of the product. Their acclaimed effects have never been tested or confirmed independently, neither in vitro nor in vivo, and the alleged clinical improvements cannot thus be differentiated from a placebo effect.

Clinical results

Even if some clinical reports of the ‘70s are subject to justified criticism, hundreds of studies have established the efficacy of transfer factor in treating several pathologies. Its lack of toxicity and the absence of side effects made the use of this extract appealing. Moreover, despite current scepticism, no publication has ever rejected reported clinical claims. An impressive number of clinical studies have demonstrated the efficacy of transfer factor in treating and even preventing viral infections. For instance, Steele and co-workers were able to protect leukaemic children receiving chemotherapy from varicella zoster virus infections using varicella-zoster-specific transfer factor. In the early 1980s, Viza and Dwyer described significant improvement obtained by the use of herpes-simplex-virus-specific transfer factor in treating patients suffering from recurrent genital and/or labial herpes. The clinical observations were later corroborated by experiments in a mouse model.

Other clinical studies have shown that specific transfer factor may produce a spectacular improvement in acute cytomegalovirus (CMV) infections. Moreover, in Africa, children suffering from Burkitt’s lymphoma (a tumour caused by EBV) treated over a long period with EBV-specific TF showed a significant decrease in the rate of relapses. Other viral infections e.g. hepatitis B respond equally well to specific TF.

Transfer factor treatment has proven to be helpful in several neoplasias. One should cite the pioneering work of Fudenberg and that of Pizza. Osteosarcoma, melanoma, breast, lung, prostate and kidney cancer patients have benefited from TF therapy.

Parasitic infections also respond to TF therapy as the data of Sharma, confirmed by Delgado, in treating cutaneous leishmaniasis suggest. Other parasitic diseases known to respond effectively to TF are schistosomiasis and cryptosporidiosis, and several reports cite positive results obtained in treating patients with mycobacterial infections such as lepromatus leprosy, mycobacterium fortuitum pneumonia refractory to antibiotic therapy and tuberculosis. Chronic mucocutaneous candidiasis, an immunodeficiency characterized by chronically relapsing Candida albicans infections also responds well to TF treatment. _____________________________________________________________________________

A Short Bibliography

____________________

Ablashi DV, Levine PH, De Vinci C, Whitman JE Jr, Pizza G, Viza D: Use of anti HHV-6 transfer factor for the treatment of two patients with Chronic Fatigue Syndrome (CFS). Two case reports. Biotherapy 1996; 9: 81-86.

Bilello P, Fishman M, Koch G: Evidence that immune RNA is messenger RNA. Cell Immunol 1976; 23: 309.

Boucheix C, Phillips J, Pizza G, Sartorio C, Viza D: Activity of animal transfer factor in man. Lancet 1977; i: 189-99.

Burger DR, Vandenbark AA, Dunnic W, Kraybill WG, Vetto RM: Properties of human transfer factor from KLH-immunized donors: Dissociation of dermal transfer and proliferation augmenting activities. J Reticuloendothel Soc 1976; 24: 385-402.

Chang Y, Cesarman E, Pessin MS et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266: 1865-1869.

Delgado O, Romano EL, Belfort E, Pifano F, Scorza JV, Rojas Z: Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis. Clin Immunol Immunopathol 1981; 19: 351-358.

Dwyer JM: The use of antigen-specific transfer factor in the management of infections with herpes viruses. In: C.H. Kirkpatrick et al. (eds.) Immunobiology of Transfer Factor. Academic Press, New York 1983: 233-243.

Fernandez-Ortega C, Dubed M, Ruibal O, Vilarrubia OL, Menendez de San Pedro JC, Navea L, Ojeda M, Arana MJ: Inhibition of in vitro HIV infection by dialysable leucocyte extracts. Biotherapy 1996; 9: 33-40.

Fudenberg HH, Fudenberg HL: Transfer factor: Past, present and future. In E. Jucker (ed.): Annual Review of Pharmacology and Toxicology. Birkhäuser Verlag, Basel, Switzerland 1989: 475-516.

Fudenberg HH, Levin AS, Spitler LE, Wybran J, Byers V: The therapeutic uses of transfer factor. Hosp Pract 1974; 9: 95-104.

Fujisawa T, Yamaguchi Y: Postoperative immunostimulation after complete resection improves survival of patients with stage 1 nonsmall cell lung carcinoma. Cancer 1996; 78: 1892-1898.

Galbraith GMP, Fudenberg HH: Transfer factor. In: J. Stone (ed.) : Dermatologic Immunology and Allergy. Mosby, St. Louis, Mo 1985: 889-98.

Gottlieb AA, Sizemore RC, Gottlieb MS, Kern CH: Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease. Biotherapy 1996; 9: 27-31.

Griscelli C, Revillard JP, Betuel H, Herzog C, Touraine JL: Transfer factor therapy in immunodeficiencies. Biomedicine 1973; 18: 220-227.

Hastings RC, Morales MJ, Shannon EJ, Jacobson RR: Preliminary results in the safety and efficacy of transfer factor in leprosy. In: M.S. Asher, A.A. Gottlieb, C.H. Kirkpatrick (eds.): Transfer Factor: Basic Properties and Clinical Applications. Academic Press, New York 1976: 465-76.

Kirkpatrick C.H, Transfer Factors: Identification of Conserved Sequences in Transfer Factor Molecules. Mol Med 2000; 6(4): 332-341. Kirkpatrick CH, Greenberg LE: Treatment of chronic mucocutaneaous candidiasis with transfer factor. In: A. Khan, C.H. Kirkpatrick, N.O. Hill (eds.): Immune Regulators in Transfer Factor. Academic Press, New York 1979: 547-62.

Lawrence HS, Borkowsky W: Transfer Factor – Current status and future prospects. Biotherapy 1996; 9: 1-5.

Lawrence HS: The transfer in humans of delayed skin sensitivity to streptococci M substance and to tuberculin with disrupted leukocytes. J Clin Inv 1955; 34: 219-32.

Lesser PG, Margarido L, Bolda W, Sartori SG, Hares WA, Freire CA, Fleury R, Montenegro MR, Leser W, Naspitz CK: Cell-mediated immunity in patients with Virchowian Hanseniasis before and after treatment with transfer factor. Hansenol Int J 1980; 5(1); 3-27-34.

Levin AS, Byers VS, Fudenberg HH et al.: Osteogenic sarcoma: Immunologic parameters before and during immunotherapy with tumor specific transfer factor. J Clin Invest 1975; 55: 487-499.

Levin AS, Spitler LE, Stites DP, Fudenberg HH: Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory response to therapy with transfer factor. PNAS 1970; 67: 821.

Masi M, De Vinci C, Baricordi OR: Transfer factor in chronic mucocutaneaous candidiasis. Biotherapy 1996; 9: 97-103.

McMeeking A, Borkowski W, Klesius PH, Bonk S, Holzman RS, Lawrence HS: A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J Infec Dis 1990; 161: 108-12. Meduri R, Campos E, Scorolli L, De Vinci C, Pizza G, Viza D: Efficacy of transfer factor in treating patients with recurrent ocular herpes infections. Biotherapy 1996; 9: 61-66.

Metcalf JF, John JF Jr, Wilson GB, Fudenberg HH, Harley RA: Mycobacterium-fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity. Am J Med 1981; 71: 485-491.

Neequaye J, Viza D, Pizza G, Levine PH, De Vinci C, Ablashi DV, Biggar RJ, Nkrumah F: Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt’s lymphoma. Anticanc R 1990; 10: 1183-1187.

Nkrumah F, Pizza G, Viza D, Phillips J, De Vinci C, Levine P: Regression of progressive lymphadenopathy in a young child with acute CMV infection following the administration of transfer factor with specific anti-CMV activity. Lymphok Res 1985; 4: 237-241.

Pilotti V, Mastrorilli M, Pizza G, DeVinci C, Busutti L, Palareti A, Gozetti G, Cavallari A: Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy 1996; 9: 117-121.

Pizza G, Chiodo F, Colangeli V, Gritti F, Raise E, Fudenberg HH, De Vinci C, Viza D: Preliminary observations using HIV-specific transfer factor in AIDS. Biotherapy 1996; 9: 41-47.

Pizza G, De Vinci C, Cuzzocrea D, Menniti D, Aiello E, Maver P, Corrado G, Romagnoli P, Dragoni E, LoConte G, Riolo U, Palareti A, Zucchelli P, Fornarola V, Viza D: A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy 1996; 9: 123-132.

Pizza G, Viza D, De Vinci C, Palareti A, Cuzzocrea D, Fornarola V, Baricordi R: Orally administered HSV-specific transfer factor (transfer factor) prevents genital or labial herpes relapses. Biotherapy 1996; 9: 67-72.

Pizza G, Viza D, Roda A, Aldini R, Roda E, Barbara L: Transfer factor for the treatment of chronic active hepatitis. N Eng J Med 1979; 300: 1332.

Prasad U, bin Jalaludin MA, Rajadurai P, Pizza G, De Vinci C, Viza D, Levine PH: Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: A pilot study. Biotherapy 1996; 9: 109-115.

Rappaport FT, Lawrence HS, Millar JW, Pappagianis D, Smith CE: Transfer of delayed hypersensitivity to coccidioidin in man. J Immunol 1960; 84: 358-67.

Rosenfeld F, Viza D, Phillips J, Vich JM, Binet O, Aron-Brunctière R: Traitement des infections herpétiques par le facteur de transfert. Presse Méd 1984; 13: 537-40.

Sharma MK, Anaraki F, Ala F: Preliminary results of transfer factor therapy of persistent cutaneous leishmania infection. Clin Immunol Immunopathol 1979; 12: 183-190.

Spitler LE, Levin AS, Stites DP, Fudenberg HH, Pirofsky B, August CS, Stiehm ER, Hitzig WH, Gatti RA: The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest 1972; 51: 3216-24.

Steele WR, Myers MG, Vincent MM: Transfer factor for the prevention of varicella zoster infection in childhood leukaemia. N Eng J Med 1980; 303: 355-59.

Steele WR: Transfer factor and cellular reactivity to varicella zoster antigen in childhood leukaemia. Cell Immun 1980; 50: 202-89.

Vich JM, Viza D: Specific suppressor dialysates from mice. In: C.H. Kirkpatrick, D.R. Burger, H.S. Lawrence (eds.): Immunobiology of Transfer Factor. Academic Press, New York 1983: 197-202.

Vich JM, Garcia JV, Engel P, Garcia PA: Transfer to man of sensitization to Keyhole Limpet Haemocyanin by mouse transfer factor. Lancet 1978; i: 265.

Viza D, Goust JM, Moulias R, Trejdosiewicz LK, Collard A, Müllet-Bérat N: In vitro production of transfer factor by lymphoblastoid cell lines. Transplant 1975; VII (suppl. 1): 329-333.

Viza D, Lefesvre A, Patrasco M, Phillips J et al.: A preliminary report on three AIDS patients treated with anti-HIV specific transfer factor. J Exp Path 1987; 3: 653-659.

Viza D, Vich JM, Minarro A, Ablashi DV, Salahuddin SZ: Soluble extracts from a lymphoblastoid cell line modulate SAIDS evolution. J Virol Met 1988; 21: 241-253.

Viza D, Vich JM, Phillips J, Rosenfeld F, Davies DAL: Specific transfer factor protects mice against lethal challenge with herpes simplex virus. Cell Immun 1986; 100: 555-562.

Viza D, Vich JM, Phillips J, Rosenfeld F: Orally administered specific transfer factor for the treatment of herpes infections. Lymphok Res 1985; 4: 27-30.

Wilson GB, Metcalf JF Jr, Fudenberg HH: Treatment of mycobacterium-fortuitum pulmonary infection with “transfer factor” (TF): New methodology for evaluating TF potency and predicting clinical response. Clin Immunol Immunopathol 1982; 23: 478-483. _____________________________________________________________________________

                    EXTENSIVE BIBLIOGRAPHY
                   ________________________

1949 PROC SOC EXP BIOL MED 71: 516-522 LAWRENCE HS THE CELLULAR TRANSFER OF CUTANEOUS HYPERSENSITIVITY TO TUBERCULIN IN MAN

1954 JOURNAL OF CLINICAL INVESTIGATION 33(6):951-952 LAWRENCE HS THE TRANSFER OF GENERALIZED CUTANEOUS HYPERSENSITIVITY OF THE DELAYED TUBERCULIN TYPE IN MAN BY MEANS OF THE CONSTITUENTS OF DISRUPTED LEUCOCYTES

1955 AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES 71(1):49-73 PEPYS J THE RELATIONSHIP OF NONSPECIFIC AND SPECIFIC FACTORS IN THE TUBERCULIN REACTION - A REVIEW

1955 AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES 72(5):577-600 ONEILL EF; FAVOUR CB TISSUE CULTURE ANALYSIS OF TUBERCULIN HYPERSENSITIVITY IN MAN

1955 ANNUAL REVIEW OF MEDICINE 6():125-152 COOKE RA; SMITH JM; SKAGGS JT ALLERGY AND IMMUNOLOGY

1955 JOURNAL OF CLINICAL INVESTIGATION 34(2):219-230 LAWRENCE HS TRANSFER IN HUMANS OF DELAYED SKIN SENSITIVITY TO STREPTOCOCCAL-M SUBSTANCE AND TO TUBERCULIN WITH DISRUPTED LEUCOCYTES

1955 JOURNAL OF EXPERIMENTAL MEDICINE 101(4):391-420 COLE LR; FAVOUR CB CORRELATIONS BETWEEN PLASMA PROTEIN FRACTIONS, ANTIBODY TITERS, AND THE PASSIVE TRANSFER OF DELAYED AND IMMEDIATE CUTANEOUS REACTIVITY TO TUBERCULIN PPD AND TUBERCULOPOLYSACCHARIDES

1955 JOURNAL OF IMMUNOLOGY 75(4):259-264 PAPPENHEIMER AM USE OF DIPHTHERIA TOXIN AND TOXOID IN THE STUDY OF IMMEDIATE AND DELAYED HYPERSENSITIVITY IN MAN

1956 AMERICAN JOURNAL OF MEDICINE 20(3):428-447 LAWRENCE HS DELAYED TYPE OF ALLERGIC INFLAMMATORY RESPONSE

1956 AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES 73(2):246-250 CUMMINGS MM; PATNODE RA; HUDGINS PC PASSIVE TRANSFER OF TUBERCULIN HYPERSENSITIVITY IN GUINEA PIGS USING CELLS DISRUPTED BY SONIC VIBRATION

1956 JOURNAL OF ALLERGY 27(3):199-212 RAFFEL S BACTERIAL HYPERSENSITIVITY

1956 JOURNAL OF EXPERIMENTAL MEDICINE 104(3):321-329 LAWRENCE HS; PAPPENHEIMER AM TRANSFER OF DELAYED HYPERSENSITIVITY TO DIPHTHERIA TOXIN IN MAN

1956 JOURNAL OF EXPERIMENTAL MEDICINE 104(6):935-945 EHRENKRANZ NJ; WAKSMAN BH FAILURE TO TRANSFER TUBERCULIN SENSITIVITY PASSIVELY WITH PLASMA FRACTIONS CONTAINING ALPHA-GLOBULIN

1956 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 93(2):253-255 WARWICK WJ; PAGE A; GOOD RA PASSIVE TRANSFER WITH CIRCULATING LEUKOCYTES OF DELAYED HYPERSENSITIVITY TO CAT SCRATCH ANTIGEN

1957 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 64(5):826-835 LAWRENCE HS SIMILARITIES BETWEEN HOMOGRAFT REJECTION AND TUBERCULIN-TYPE ALLERGY - A REVIEW OF RECENT EXPERIMENTAL FINDINGS

1957 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 64(5):882-928 GOOD RA; VARCO RL; AUST JB; ZAK SJ TRANSPLANTATION STUDIES IN PATIENTS WITH AGAMMAGLOBULINEMIA

1957 HARVEY LECTURES (52):100-118 PAPPENHEIMER AM HYPERSENSITIVITY OF THE DELAYED TYPE

1957 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 10(4):193-224 FAVOUR CB CELL INJURY IN ALLERGIC INFLAMMATION

1957 JOURNAL OF ALLERGY 28(1):30-39 CHASE M MECHANISM OF SENSITIZATION

1957 JOURNAL OF BACTERIOLOGY 74(5):680-683 JETER WS; LAURENCE KA; SEEBOHM PM ANALYSIS OF LEUKOCYTIC EXTRACTS FROM GUINEA PIGS HYPERSENSITIVE TO TUBERCULIN AND 2,4-DINITROCHLOROBENZENE

1957 JOURNAL OF CELLULAR AND COMPARATIVE PHYSIOLOGY 50():247-264 MITCHISON NA ADOPTIVE TRANSFER OF IMMUNE REACTIONS BY CELLS

1957 JOURNAL OF CLINICAL INVESTIGATION 36(6):908-909 LAWRENCE HS; PAPPENHEIMER AM EFFECT OF SPECIFIC ANTIGEN ON RELEASE FROM HUMAN LEUCOCYTES OF THE FACTOR CONCERNED IN TRANSFER OF DELAYED HYPERSENSITIVITY

1957 JOURNAL OF EXPERIMENTAL MEDICINE 105(1):11-24 UHR JW; SALVIN SB; PAPPENHEIMER AM DELAYED HYPERSENSITIVITY .2. INDUCTION OF HYPERSENSITIVITY IN GUINEA PIGS BY MEANS OF ANTIGEN-ANTIBODY COMPLEXES

1957 JOURNAL OF INVESTIGATIVE DERMATOLOGY 28(4):291-304 EPSTEIN WL; KLIGMAN AM TRANSFER OF ALLERGIC CONTACT-TYPE DELAYED SENSITIVITY IN MAN

1958 AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES 78(3):346-352 OLIVEIRALIMA A PASSIVE TRANSFER OF THE DELAYED DERMAL SENSITIVITY TO TUBERCULIN BY MEANS OF BLOOD LEUKOCYTES - IMPEDIENT EFFECT OF SPECIFIC DESENSITIZATION

1958 BLOOD 13(5):417-426 BRAUNSTEINER H; PAERTAN J; THUMB N STUDIES ON LYMPHOCYTIC FUNCTION

1958 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 12(1-2):35-41 PAPPENHEIMER AM THE SCHICK TEST, 1913-1958

1958 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 12(5):287-304 STOLLERMAN GH A SCARLATINAL NACHKRANKHEIT OF SCHICK - RHEUMATIC FEVER, 50 YEARS LATER

1958 JOURNAL OF EXPERIMENTAL MEDICINE 108(6):891-904 UHR JW; PAPPENHEIMER AM DELAYED HYPERSENSITIVITY .3. SPECIFIC DESENSITIZATION OF GUINEA PIGS SENSITIZED TO PROTEIN ANTIGENS

1958 JOURNAL OF IMMUNOLOGY 80(5):362-366 WALLACE JH LEUKOCYTIC TRANSFER OF DELAYED SENSITIVITY TO NORMAL GUINEA PIGS FROM RATS INFECTED WITH MYCOBACTERIUM-LEPRAEMURIUM

1958 PROGRESS IN ALLERGY 5():149-214 BOYDEN SV THE IMMUNOLOGICAL RESPONSE TO ANTIGENS OF THE TUBERCLE BACILLUS - SOME EXPERIMENTAL ASPECTS

1958 PROGRESS IN ALLERGY 5():271-348 BRENT L TISSUE TRANSPLANTATION IMMUNITY

1958 PROGRESS IN ALLERGY 5():349-458 WAKSMAN BH CELL LYSIS AND RELATED PHENOMENA IN HYPERSENSITIVE REACTIONS, INCLUDING IMMUNOHEMATOLOGIC DISEASES

1959 AMERICAN JOURNAL OF OPHTHALMOLOGY 48(1):57-71 SERY TW RANDOM OCCURRENCE OF HERPETIC DISCIFORM KERATITIS IN RABBITS

1959 FEDERATION PROCEEDINGS 18(1):593-593 RAPAPORT FT; LAWRENCE HS; MILLAR JW; PAPPAGIANIS D; SMITH CE TRANSFER OF DELAYED COCCIDIOIDIN HYPERSENSITIVITY WITH LEUCOCYTE EXTRACTS IN MAN

1959 JOURNAL OF PATHOLOGY AND BACTERIOLOGY 77(1):219-230 MCLEOD JA; MCLEOD JW OSCILLATION OF THE INTRALEUCOCYTIC GRANULES AS A CRITERION OF SURVIVAL OF THE LEUCOCYTE AND OF THE POTENCY OF CYTOTOXIC AGENTS

1959 PHYSIOLOGICAL REVIEWS 39(4):811-859 LAWRENCE HS HOMOGRAFT SENSITIVITY - AN EXPRESSION OF THE IMMUNOLOGIC ORIGINS AND CONSEQUENCES OF INDIVIDUALITY

1960 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 87(1):217-222 RAPAPORT FT; THOMAS L; CONVERSE JM; LAWRENCE HS THE SPECIFICITY OF SKIN HOMOGRAFT REJECTION IN MAN

1960 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 87(1):223-230 LAWRENCE HS; RAPAPORT FT; CONVERSE JM; TILLETT WS ANTIGEN-ANTIBODY MANIFESTATIONS IN TISSUE TRANSPLANTATION .3. THE TRANSFER OF HOMOGRAFT SENSITIVITY (ACCELERATED REJECTION) WITH DNASE-TREATED LEUKOCYTE EXTRACTS IN MAN

1960 ANNUAL REVIEW OF MEDICINE 11():207-230 LAWRENCE HS DELAYED SENSITIVITY AND HOMOGRAFT SENSITIVITY

1960 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 85(17):741-& GRUNDMANN E NEW FINDINGS ABOUT THE ORIGIN AND IMPORTANCE OF THE LYMPHOCYTES

1960 GASTROENTEROLOGY 38(4):536-562 KIRSNER JB; GOLDGRABER MB HYPERSENSITIVITY, AUTOIMMUNITY, AND THE DIGESTIVE TRACT

1960 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 17(5-6):338-351 TURK JL SOME QUANTITATIVE ASPECTS OF THE UPTAKE OF ANTIGENS INVITRO BY THE LYMPHOCYTES OF HYPERSENSITIVE GUINEA PIGS

1960 JOURNAL OF CLINICAL INVESTIGATION 39(1):185-198 LAWRENCE HS; RAPAPORT FT; CONVERSE JM; TILLETT WS TRANSFER OF DELAYED HYPERSENSITIVITY TO SKIN HOMOGRAFTS WITH LEUKOCYTE EXTRACTS IN MAN

1960 JOURNAL OF IMMUNOLOGY 84(4):358-367 RAPAPORT FT; LAWRENCE HS; MILLAR JW; PAPPAGIANIS D; SMITH CE TRANSFER OF DELAYED HYPERSENSITIVITY TO COCCIDIOIDIN IN MAN

1960 JOURNAL OF IMMUNOLOGY 84(4):368-373 RAPAPORT FT; LAWRENCE HS; MILLAR JW; PAPPAGIANIS D; SMITH CE IMMUNOLOGIC PROPERTIES OF COCCIDIOIDIN AS A SKIN TEST REAGENT IN MAN

1960 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 56(1):139-147 WARWICK WJ; GOOD RA; SMITH RT FAILURE OF PASSIVE TRANSFER OF DELAYED HYPERSENSITIVITY IN THE NEWBORN HUMAN INFANT

1960 KLINISCHE WOCHENSCHRIFT 38(18):900-902 REMY D HUMORALE FUNKTIONEN WEISSER BLUTZELLEN

1961 ADVANCES IN CANCER RESEARCH 6():181-289 KOLLER PC; DAVIES AJS; DOAK SMA RADIATION CHIMERAS

1961 ADVANCES IN IMMUNOLOGY 1():319-343 GELL PGH; BENACERRAF B DELAYED HYPERSENSITIVITY TO SIMPLE PROTEIN ANTIGENS

1961 AMERICAN REVIEW OF RESPIRATORY DISEASE 83(3):372-& PAAS CM; RUDD JH; KAPRAL FA; FLICK JA ON PERSISTENCE OF TUBERCULIN HYPERSENSITIVITY IN GUINEA PIGS MADE SENSITIVE PASSIVELY

1961 ANNALES DE L INSTITUT PASTEUR 101(3):327-& WAHL R; DRACH G MODIFICATIONS DE LA REACTIVITE DU LAPIN (ALLERRGIE) DETERMINEES PAR LES INOCULATIONS SOUS-CUTANEES DE STREPTOCOCCUS PYOGENES (GROUPE A) .2. EFFET DES REINOCULATIONS PRATIQUEES APRES LAPPARITION DE LA REACTIVITE CUTANEE

1961 JOURNAL OF ALLERGY 32(3):229-& BECKER RJ; PATTERSON R; SPARKS DB; PRUZANSKY JJ; FEINBERG AR; FEINBERG SM DELAYED AND IMMEDIATE SKIN REACTIVITY IN MAN AFTER INJECTION OF ANTIGEN IN EMULSION - CELL TRANSFER OF DELAYED SENSITIVITY

1961 JOURNAL OF CLINICAL INVESTIGATION 40(12):2162-& FRIEDMAN EA; HENRY L; MARSHALL DC; MERRILL JP; RETAN JW ACCELERATED SKIN GRAFT REJECTION IN HUMANS PREIMMUNIZED WITH HOMOLOGOUS PERIPHERAL LEUKOCYTES

1961 JOURNAL OF EXPERIMENTAL MEDICINE 113(6):1029-& MAURER PH IMMUNOLOGIC STUDIES WITH ETHYLENE OXIDE-TREATED HUMAN SERUM

1961 JOURNAL OF EXPERIMENTAL MEDICINE 114(4):509-& KRETSCHM.R; PEREZTAMAYO R ROLE OF HUMORAL ANTIBODIES IN REJECTION OF SKIN HOMOGRAFTS IN RABBITS .1. PASSIVE TRANSFER OF ISOIMMUNE SERUM TO CONDITIONED HOSTS

1961 JOURNAL OF EXPERIMENTAL MEDICINE 114(5):779-& NAJARIAN JS; FELDMAN JD PASSIVE TRANSFER OF TUBERCULIN SENSITIVITY BY TRITIATED THYMIDINE-LABELED LYMPHOID CELLS

1961 JOURNAL OF EXPERIMENTAL ZOOLOGY 148(2):147-& STEINMULLER D TRANSPLANTATION IMMUNITY IN NEWBORN RAT .2. TRANSFER OF IMMUNITY TO NEWBORN RECIPIENTS

1961 JOURNAL OF INVESTIGATIVE DERMATOLOGY 37(5):333-336 MARCH C; WITTEN VH; ROSENTHAL S STUDIES OF THE MECHANISM OF ALLERGIC ECZEMATOUS CONTACT DERMATITIS .3. INVITRO REACTION OF MONONUCLEAR CELLS WITH RADIOACTIVELY LABELED ALLERGEN

1961 NATURE 189(476):889-& TURK JL ACTIVE SENSITIZATION TO TUBERCULIN WITH CELLS FROM TUBERCULIN- SENSITIZED GUINEA PIGS

1961 NATURE 190(477):355-& JOHANOVSKY J PRODUCTION OF PYROGENIC SUBSTANCES BY EXTRACTS OF DELAYED HYPERSENTIVE CELLS MIXED WITH ANTIGEN IN-VITRO

1962 AMERICAN REVIEW OF RESPIRATORY DISEASE 85(3):373-& JENSEN K; TOWNSLEY HC; PATNODE RA; CUMMINGS MM MULTIPLE PASSIVE TRANSFER OF DELAYED TYPE OF HYPERSENSITIVITY IN HUMANS

1962 ANNALS OF SURGERY 156(3):356-& MANNICK JA; EGDAHL RH TRANSFORMATION OF NONIMMUNE LYMPH NODE CELLS TO STATE OF TRANSPLANTATION IMMUNITY BY RNA - A PRELIMINARY REPORT

1962 JOURNAL OF ALLERGY 33(6):498-& BARAM P; MOSKO MM CHROMATOGRAPHY OF HUMAN TUBERCULIN DELAYED-TYPE HYPERSENSITIVITY TRANSFER FACTOR

1962 JOURNAL OF EXPERIMENTAL MEDICINE 115(3):475-& FONG J; CHIN D; ELBERG SS STUDIES ON TUBERCLE BACILLUS-HISTIOCYTE RELATIONSHIP .5. PASSIVE TRANSFER OF CELLULAR RESISTANCE

1962 JOURNAL OF EXPERIMENTAL MEDICINE 116(6):879-& KRETSCHMER RR; PEREZTAMAYO R ROLE OF HUMORAL ANTIBODIES IN REJECTION OF SKIN HOMOGRAFT IN RABBITS .2. PASSIVE TRANSFER OF TRANSPLANTATION IMMUNITY BY SENSITIZED LYMPH NODE CELLS WITHIN DIFFUSION CHAMBERS

1962 JOURNAL OF IMMUNOLOGY 89(4):555-& LAMB D; PILNEY F; GOOD RA; KELLY WD A COMPARATIVE STUDY OF INCIDENCE OF ANERGY IN PATIENTS WITH CARCINOMA, LEUKEMIA, HODGKINS DISEASE AND OTHER LYMPHOMAS

1962 JOURNAL OF IMMUNOLOGY 89(4):571-& JANKOVIC BD; DVORAK HF ENZYMATIC INACTIVATION OF IMMUNOLOGICALLY COMPETENT LYMPH NODE CELLS IN TRANSFER REACTION

1962 JOURNAL OF INVESTIGATIVE DERMATOLOGY 38(6):363-369 FREEDMAN SO; FISH AJ THE PASSIVE CELLULAR TRANSFER OF DELAYED TYPE HYPERSENSITIVITY TO INTRADERMAL PROCAINE

1962 NATURE 193(4821):1198-& POWELL AE; RAY O; HUBAY CA; WHITENAC.D; HOLDEN WD A SKIN REACTION IN GUINEA PIG HOMOGRAFT DONORS WITH A CELL-FREE SUBSTANCE FROM RECIPIENT LYMPH NODES

1962 NEW ENGLAND JOURNAL OF MEDICINE 267(22):1105-& SCHWARTZ RS; DAMESHEK W; LEWIS FB HEMORRHAGIC CUTANEOUS ANAPHYLAXIS DUE TO AUTOSENSITIZATION TO DEOXYRIBONUCLEIC ACID

1962 PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 156(963):187-& BRENT L; BROWN JB; MEDAWAR PB QUANTITATIVE STUDIES ON TISSUE TRANSPLANTATION IMMUNITY .6. HYPERSENSITIVITY REACTIONS ASSOCIATED WITH REJECTION OF HOMOGRAFTS

1962 PROGRESS IN ALLERGY 6():187-319 GOOD RA; KELLY WD; ROTSTEIN J; VARCO RL IMMUNOLOGICAL DEFICIENCY DISEASES - AGAMMAGLOBULINEMIA, HYPOGAMMAGLOBULINEMIA, HODGKINS DISEASE AND SARCOIDOSIS

1963 TRANS ASSOC AMER PHYS LXXVI: 84-91 AL-ASKARI S ET AL TRANSFER OF IMMUNOLOGICAL INFORMATION IN HUMANS WITH DIALYSATES OF LEUCOCYTE EXTRACTS

1963 ACTA ALLERGOLOGICA 18(2):156-& MOSCHOS TD; SERRI F PASSIVE TRANSFER OF ALLERGIC ECZEMATOUS CONTACT-TYPE SENSITIVITY

1963 ANNALES DE L INSTITUT PASTEUR 105(3):465-& WAKSMAN BH LES BASES CELLULAIRES DE LA REPONSE IMMUNITAIRE

1963 ANNUAL REVIEW OF MICROBIOLOGY 17():263-& BENACERRAF B; MCCLUSKEY RT METHODS OF IMMUNOLOGIC INJURY TO TISSUES

1963 ANNUAL REVIEW OF MICROBIOLOGY 17():531-& BILLINGHAM RE; SILVERS WK SENSITIVITY TO HOMOGRAFTS OF NORMAL TISSUES AND CELLS

1963 ARCHIVES OF DERMATOLOGY 88(6):799-& NEWCOMER VD; ROWE JR; LEHMAN R; LANDAU JW LOCAL CELLULAR RESPONSE IN PATIENTS WITH COCCIDIOIDOMYCOSIS

1963 DISEASES OF THE CHEST 43(4):393-396 BOVORNKITTI S; KANGSADAL P; LIMPANICHAKARN S; INDANIYOM C SERUM TRANSFER OF DELAYED CUTANEOUS HYPERSENSITIVITY TO TUBERCULIN IN MAN

1963 JOURNAL OF IMMUNOLOGY 90(1):52-& FREEDMAN SO; FISH AJ; TURCOTTE R; SEHON AH IN VITRO DETECTION OF CELL-FIXED HEMAGGLUTINATING ANTIBODIES TO TUBERCULIN PURIFIED PROTEIN DERIVATIVE (PPD) IN HUMANS

1963 JOURNAL OF IMMUNOLOGY 90(2):209-& GORDON M STUDIES ON RELATIONSHIP OF DELAYED HYPERSENSITIVITY TO IMMUNITY IN TULAREMIA

1963 JOURNAL OF IMMUNOLOGY 90(3):337-& STEFFEN C; ROSAK M IN VITRO DEMONSTRATION OF ANTI-OVALBUMIN SPECIFICITY OF LYMPH NODE CELLS IN DELAYED TYPE HYPERSENSITIVITY

1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 113(3):627-& KLEIN GC; PATNODE RA SERUM PROTEIN CHANGE IN RESPONSE TO POSITIVE TUBERCULIN SKIN TEST IN HUMANS

1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 113(3):650-& WALLRAFF EB WARBURG STUDIES ON COCCIDIOIDIN

1963 PROGRESS IN ALLERGY 7():213-331 SALVIN SB IMMUNOLOGIC ASPECTS OF THE MYCOSES

1963 TEXAS REPORTS ON BIOLOGY AND MEDICINE 21(2):136-& HEILMAN DH TISSUE CULTURE METHODS FOR STUDYING DELAYED ALLERGY - A REVIEW

1963 TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS 76():84-91 LAWRENCE HS; ALASKARI S; DAVID J; FRANKLIN EC; ZWEIMAN B TRANSFER OF IMMUNOLOGICAL INFORMATION IN HUMANS WITH DIALYSATES OF LEUCOCYTE EXTRACTS

1963 TRANSPLANTATION 1(4):495-501 NAJARIAN JS; FELDMAN JD OBSERVATIONS ON THE PASSIVE TRANSFER OF TRANSPLANTATION IMMUNITY AND DELAYED HYPERSENSITIVITY WITH LYMPHOID CELLS IN MILLIPORE CHAMBERS

1963 ZENTRALBLATT FUR BAKTERIOLOGIE PARASITENKUNDE INFEKTIONSKRANKHEITEN UND HYGIENE ABTEILUNG 1 191(1):260-268 GILLISSEN G ZELLFREIE PRAPARATE DES SOG TRANSFER-FAKTORS BEI DER TUPERKULINALLERGIE BEIM TIER

1964 ACTA CIENTIFICA VENEZOLANA 15(1):22-29 KUCHARSKI WE; FAVOUR CB TRANSFERENCIA PASIVA DE LA SENSIBILIDAD TARDIA A LA TUBERCULINA EN COBAYOS CON MATERIAL DESPROVISTO DE CELULAS

1964 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 24(4):209-19 LEBACQ E; VERHAEGEN H PASSIVE TRANSFER OF KWEIM REACTION TO NORMAL SUBJECTS BY MEANS OF LEUCOCYTES OF SARCOIDOSIS PATIENTS

1964 JOURNAL OF ALLERGY 35(3):242-58 ROWLANDS DT; KIRKPATRICK CH; WILSON WEC IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION .II. HISTOLOGY OF PASSIVELY TRANSFERRED DELAYED HYPERSENSITIVITY

1964 JOURNAL OF CLINICAL INVESTIGATION 43(11):2166-71 MANNICK JA; EGDAHL RH TRANSFER OF HEIGHTENED IMMUNITY TO SKIN HOMOGRAFTS BY LYMPHOID RNA

1964 JOURNAL OF EXPERIMENTAL MEDICINE 120(6):1151-69 FINSTAD J; GOOD RA EVOLUTION OF IMMUNE RESPONSE .3. IMMUNOLOGIC RESPONSES IN LAMPREY

1964 JOURNAL OF IMMUNOLOGY 92(1):73-82 POWELL AE; HUBAY CA; HOLDEN WD; RAY O INDUCED REJECTION OF GUINEA PIG SKIN HOMOGRAFTS BY PARTIALLY PURIFIED TRANSFER FACTOR

1964 JOURNAL OF IMMUNOLOGY 93(6):953-68 MARTINS AB; MOORE WD; DICKINSO.JB; RAFFEL S CELLULAR ACTIVITIES IN HYPERSENSITIVE REACTIONS .3. SPECIFICALLY REACTIVE CELLS IN DELAYED HYPERSENSITIVITY - TUBERCULIN HYPERSENSITIVITY

1964 NEW ENGLAND JOURNAL OF MEDICINE 271(11):553-67 RUSSELL PS; MONACO AP BIOLOGY OF TISSUE TRANSPLANTATION

1964 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 115(2):374-82 KUCHARSKY W; FAVOUR CB TRANSFER OF CUTANEOUS HYPERSENSITIVITY TO TUBERCULIN WITH CELL- FREE EXTRACT OF SPLENIC TISSUE

1964 SCIENCE 145(362):52-55 SLAVIN RG; GARVIN JE DELAYED HYPERSENSITIVITY IN MAN - TRANSFER BY LYMPHOCYTE PREPARATIONS OF PERIPHERAL BLOOD

1964 SURGERY 56(1):249-255 MANNICK JA TRANSFER OF ADOPTIVE IMMUNITY TO HOMOGRAFTS BY RNA - A PRELIMINARY REPORT

1965 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 124():56-61 LAWRENCE HS TRANSFER FACTOR AND AUTOIMMUNE DISEASE

1965 BIBLIOTHECA HAEMATOLOGICA (23P1):134-42 RAPAPORT FT; DAUSSET J; CONVERSE JM; LAWRENCE HS TRANSPLANTATION REACTIONS IN HUMANS

1965 IMMUNOLOGY 8(5):461-75 BARAM P; MOSKO MM A DIALYSABLE FRACTION FROM TUBERCULIN-SENSITIVE HUMAN WHITE BLOOD CELLS CAPABLE OF INDUCING TUBERCULIN-DELAYED HYPERSENSITIVITY IN NEGATIVE RECIPIENTS

1965 JOURNAL OF IMMUNOLOGY 95(5):834-55 CROWLE AJ; HU CC ATTEMPTS TO INDUCE EARLY-TYPE (JONES-MOTE) DELAYED HYPERSENSITIVITY IN MICE

1965 JOURNAL OF PEDIATRICS 66(1P2):262-69 GLASER J; HOLT EL; LEIDER M; FONTANA VJ; HILL LW; DANCIS J PREVENTION OF ECZEMA

1965 KLINISCHE WOCHENSCHRIFT 43(11):590-95 GILLISSE.G IMMUNOLOGISCHE GRUNDLAGEN DER ALLERGISCHEN SPATREAKTION

1965 MEDICAL CLINICS OF NORTH AMERICA 49(6):1613-19 CHASE MW DELAYED SENSITIVITY

1966 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 30(4):335-48 SCHEIFFA.F; WARNATZ H; BOCKLER L SEROLOGICAL EXPERIMENTS ABOUT ANTIBODY-AFFINITY OF LYMPHOCYTES IN ANIMALS SENSITIZED AGAINST EHRLICH-ASCITES-TUMOR

1966 JOURNAL OF ALLERGY 37(5):284-95 KOCHAN I; BENDEL WL PASSIVE TRANSFER OF TUBERCULIN HYPERSENSITIVITY IN GUINEA PIGS

1966 JOURNAL OF ALLERGY 38(5):280-& KOCHAN I; CHRISTOP.JA; KUPCHYK L STUDY ON CELLULAR FACTOR OF DELAYED HYPERSENSITIVITY

1966 JOURNAL OF IMMUNOLOGY 97(3):407-& BARAM P; YUAN L; MOSKO MM STUDIES ON TRANSFER OF HUMAN DELAYED-TYPE HYPERSENSITIVITY .I. PARTIAL PURIFICATION AND CHARACTERIZATION OF 2 ACTIVE COMPONENTS

1966 PHYSIOLOGICAL REVIEWS 46(3):359-& UHR JW DELAYED HYPERSENSITIVITY

1967 JOURNAL OF IMMUNOLOGY 99(3):467-& DUNN DJ; PATNODE RA PASSIVE TRANSFER OF TUBERCULIN HYPERSENSITIVITY WITH CELLULAR FRACTIONS FROM SENSITIZED GUINEA PIGS

1967 JOURNAL OF PEDIATRICS 70(1):126-& BROWN RE; KATZ M PASSIVE TRANSFER OF DELAYED HYPERSENSITIVITY REACTION TO TUBERCULIN IN CHILDREN WITH PROTEIN CALORIE MALNUTRITION

1967 LANCET 2(7527):1191-& [ANON] IMMUNOLOGY AND CANCER

1967 POSTGRADUATE MEDICINE 42(6):475-& DAVID JR CURRENT CONCEPTS OF DELAYED HYPERSENSITIVITY

1967 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 126(3):619-& EICHWALD EJ; LUSTGRAA.EC; WETZEL B TRANSFER OF WHITE GRAFT REACTION

1967 PROGRESS IN ALLERGY 10():151-& BLOOM BR; CHASE MW TRANSFER OF DELAYED-TYPE HYPERSENSITIVITY - A CRITICAL REVIEW AND EXPERIMENTAL STUDY IN GUINEA PIG

1967 SCIENCE 155(3760):337-& FIREMAN P; BOESMAN M; HADDAD ZH; GITLIN D PASSIVE TRANSFER OF TUBERCULIN REACTIVITY IN VITRO 1968 TRANS OF ASSOC AMER PHYS LXXXI: 240-48 LAWRENCE HS AND ZWEIMAN B TRANSFER FACTOR DEFICIENCY RESPONSE – A MECHANISM OF ANERGY IN BOECK’S SARCOID

1968 MED UNI COMM FUTURE 211-18 LAWRENCE HS TRANSFER FACTOR AND HOMOGRAFT IMMUNITY

1968 FEDERATION PROCEEDINGS 27(1):29-& FIREMAN P; BOESMAN M; HADDAD Z; GITLIN D IN VITRO PASSIVE TRANSFER OF TUBERCULIN REACTIVITY

1968 JOURNAL OF CLINICAL INVESTIGATION 47(6):A98-& VALENTIN.FT; LAWRENCE HS TRANSFER OF CELLULAR HYPERSENSITIVITY IN VITRO

132 1968 JOURNAL OF CLINICAL INVESTIGATION 47(9):2152-& BRANDRIS.MW ATTEMPT TO TRANSFER CONTACT HYPERSENSITIVITY IN MAN WITH DIALYSATE OF PERIPHERAL LEUKOCYTES

1968 JOURNAL OF EXPERIMENTAL MEDICINE 127(2):251-& KANTOR FS DELAYED HYPERSENSITIVITY .I. EFFECT OF IN VITRO EXPOSURE OF CELLS TO ANTIGEN UPON LEUKOCYTIC TRANSFER OF DELAYED HYPERSENSITIVITY

1968 JOURNAL OF IMMUNOLOGY 101(4):743-& BATTISTO JR SPONTANEOUS DELAYED ISO-HYPERSENSITIVITY IN GUINEA PIGS

1968 JOURNAL OF IMMUNOLOGY 101(5):823-& JUREZIZ RE; THOR DE; DRAY S TRANSFER WITH RNA EXTRACTS OF CELL MIGRATION INHIBITION CORRELATE OF DELAYED HYPERSENSITIVITY IN GUINEA PIG

1968 JOURNAL OF PEDIATRICS 72(6):885-& JANEWAY CA PROGRESS IN IMMUNOLOGY - SYNDROMES OF DIMINISHED RESISTANCE TO INFECTION

1968 JOURNAL OF SURGICAL RESEARCH 8(3):109-& POWELL AE; CHANDLER R; HUBAY CA; HOLDEN WD TIME OF DEVELOPMENT AND DURATION OF EFFECT OF A GUINEA PIG TRANSFER FACTOR

1968 NATURE 218(5140):426-29 BURNET FM EVOLUTION OF IMMUNE PROCESS IN VERTEBRATES

1968 NEW ENGLAND JOURNAL OF MEDICINE 278(6):333-35 [ANON] TRANSFER FACTOR AND LEPROSY

1968 TEXAS REPORTS ON BIOLOGY AND MEDICINE 26(1):5-& DANIELS JC; RITZMANN SE; LEVIN WC LYMPHOCYTES - MORPHOLOGICAL DEVELOPMENTAL AND FUNCTIONAL CHARACTERISTICS IN HEALTH DISEASE AND EXPERIMENTAL STUDY - AN ANALYTICAL REVIEW

1969 ANNALES DE L INSTITUT PASTEUR 116(5):561-& WAKSMAN BH CURRENT PROBLEMS OF DELAYED HYPERSENSITIVITY

1969 ANNUAL REVIEW OF MEDICINE 20():141-& BENACERR.B; GREEN I CELLULAR HYPERSENSITIVITY

1969 BLOOD-THE JOURNAL OF HEMATOLOGY 33(2P1):186-& SKURKOVI.SV; MAKHONOV.LA; REZNICHE.FM; CHERVONS.GI TREATMENT OF CHILDREN WITH ACUTE LEUKEMIA BY PASSIVE CYCLIC IMMUNIZATION WITH AUTOPLASMA AND AUTOLEUKOCYTES OPERATED DURING REMISSION PERIOD

1969 CANCER RESEARCH 29(7):1428-& SOUTHAM CM; DIZON QS REJECTION OF HUMAN CANCER TRANSPLANTS BY TOLERANT RATS FOLLOWING TREATMENT WITH ALLOGENEIC LYMPHOID CELLS

1969 JOURNAL OF EXPERIMENTAL MEDICINE 130(2):327-& MARSHALL WH; VALENTIN.FT; LAWRENCE HS CELLULAR IMMUNITY IN VITRO - CLONAL PROLIFERATION OF ANTIGEN- STIMULATED LYMPHOCYTES

1969 JOURNAL OF IMMUNOLOGY 103(5):1014-& PAQUE RE; KNISKERN PJ; DRAY S; BARAM P IN VITRO STUDIES WITH TRANSFER FACTOR - TRANSFER OF CELL- MIGRATION INHIBITION CORRELATE OF DELAYED HYPERSENSITIVITY IN HUMANS WITH CELL LYSATES FROM HUMANS SENSITIZED TO HISTOPLASMIN, COCCIDIOIDIN, OR PPD

1969 JOURNAL OF IMMUNOLOGY 103(5):1072-& SPITLER LE; LAWRENCE HS STUDIES OF LYMPHOCYTE CULTURE - PRODUCTS OF SENSITIVE LYMPHOCYTE-ANTIGEN INTERACTION

1969 JOURNAL OF PATHOLOGY 97(4):653-& BERRY CL MODIFICATION OF HOST RESPONSE IN EXPERIMENTAL HISTOPLASMOSIS 1969 JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 207(3):517-& MOHR JA; KILLEBRE.L; MUCHMORE HG; FELTON FG; RHOADES ER TRANSFER OF DELAYED HYPERSENSITIVITY - ROLE OF BLOOD TRANSFUSIONS IN HUMANS

1969 MEDICINA 29(3):179-& MACARIO AJL TRANSFER OF CUTANEOUS HYPERSENSITIVITY TO DIPHTHERIA TOXOID BY MEANS OF SERUM AND LYMPHOID CELLS OF DIVERSE SOURCES FROM NORMAL AND THYMECTOMIZED MICE

1969 SCIENCE 165(3897):1016-& VALENTIN.FT; LAWRENCE HS LYMPHOCYTE STIMULATION - TRANSFER OF CELLULAR HYPERSENSITIVITY TO ANTIGEN IN VITRO

1969 SEMINARS IN HEMATOLOGY 6(1):28-& MEUWISSE.HJ; STUTMAN O; GOOD RA FUNCTIONS OF LYMPHOCYTES

1970 AMERICAN JOURNAL OF PATHOLOGY 60(3):437-& LAWRENCE HS; VALENTIN.FT TRANSFER FACTOR AND OTHER MEDIATORS OF CELLULAR IMMUNITY

1970 AMERICAN REVIEW OF RESPIRATORY DISEASE 102(3):398-& GUTHRIE RK; NUNEZ WJ PASSIVE TRANSFER OF HYPERSENSITIVITY BY CELLS ENCLOSED IN MEMBRANE CHAMBERS

1970 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 169(A1):269-& LAWRENCE HS; VALENTIN.FT TRANSFER FACTOR IN DELAYED HYPERSENSITIVITY

1970 FEDERATION PROCEEDINGS 29(1):183-& LAWRENCE HS TRANSFER FACTOR, HOMOGRAFT REJECTION AND EFFECS OF ANTILYMPHOCYTE SERUM IN MAN

1970 GANN 61(2):105-& TSUKADA Y AN EXPERIMENTAL STUDY ON EFFECT OF BLOOD OR BLOOD COMPONENT TRANSFUSION TO TRANSPLANTED TUMOR CELLS

1970 JOURNAL OF IMMUNOLOGY 104(3):544-& SPITLER LE; FUDENBER.HH PRODUCTS OF INTERACTION OF ANTIGEN-SENSITIZED LEUKOCYTES AND ANTIGEN - FURTHER CHARACTERIZATION OF MITOGENIC FACTOR

1970 JOURNAL OF IMMUNOLOGY 104(4):769-& BARAM P; CONDOULI.W IN-VITRO TRANSFER OF DELAYED HYPERSENSITIVITY TO RHESUS-MONKEY AND HUMAN LYMPHOCYTES WITH TRANSFER FACTOR OBTAINED FROM RHESUS-MONKEY PERIPHERAL WHITE BLOOD CELLS

1970 JOURNAL OF PARASITOLOGY 56(6):1206-& LARSH JE; GOULSON HT; WEATHERL.NF; CHAFFEE EF STUDIES ON DELAYED (CELLULAR) HYPERSENSITIVITY IN MICE INFECTED WITH TRICHINELLA-SPIRALIS .6. RESULTS IN RECIPIENTS INJECTED WITH ANTISERUM OR FREEZE-THAW SPLEEN CELLS

1970 NEW ENGLAND JOURNAL OF MEDICINE 283(8):411-& LAWRENCE HS; LUCAS D; LAMBERT P; FEINGOLD DS; BESDINE R; STEIGBIG.N TRANSFER FACTOR AND CELLULAR IMMUNE DEFICIENCY DISEASE

1970 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 67(2):821-828 LEVIN AS; SPITLER LE; STITES DP; FUDENBER.HH WISKOTT-ALDRICH SYNDROME, A GENETICALLY DETERMINED CELLULAR IMMUNOLOGIC DEFICIENCY - CLINICAL AND LABORATORY RESPONSES TO THERAPY WITH TRANSFER FACTOR

1970 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 133(4):1175-& LARRALDE C IN-VITRO MITOTIC ACTIVITY OF UNSENSITIZED LYMPHOCYTES IN PRESENCE OF ANTIGEN AND SENSITIZED LYMPHOCYTES

1970 REVUE D IMMUNOLOGIE 34(3):155-& ESKENASY A; GALBENU P; NITZULES.G CONTRIBUTION TO IMMUNOLOGY OF SENSITISATION .9. PASSIVE CELL TRANSFER OF TUBERCULOPROTEIN HYPERSENSITIVITY DEMONSTRATED BY PULMONARY REACTION

1971 AMERICAN JOURNAL OF PATHOLOGY 65(3):653-& SANTOS GW APPLICATION OF MARROW GRAFTS IN HUMAN DISEASE

1971 ANNALS OF ALLERGY 29(4):195-& MELNICK HD INHIBITION OF MACROPHAGE MIGRATION AND MEDIATION OF CELLULAR IMMUNITY - REVIEW

1971 ANNALS OF INTERNAL MEDICINE 74(6):955-& KIRKPATR.CH; RICH RR; BENNETT JE CHRONIC MUCOCUTANEOUS CANDIDIASIS - MODEL-BUILDING IN CELLULAR IMMUNITY

1971 ANNALS OF INTERNAL MEDICINE 75(4):561-& ODUFFY JD; CARNEY JA; DEODHAR S BEHCETS DISEASE - REPORT OF 10 CASES, 3 WITH NEW MANIFESTATIONS

1971 ANNUAL REVIEW OF MEDICINE 22():25-& MCGEE ZA; SCHAFFNE.W; KOENIG MG SUPERINFECTION IN LYMPHORETICULAR DISEASES

1971 BLUT 23(5):302-& COHNEN G; BRITTING.G IMMUNE PATHOLOGIC CHANGES WITH LYMPHOGRANULOMATOSIS

1971 CALIFORNIA MEDICINE 115(4):48-& MARINKOV.VA CLINICAL USE OF TRANSFER FACTOR

1971 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D 272(23):2996-& MAYLEVIN F; GRAFFTE G; BRULE G EFFECTS OF SOLUBLE FACTORS RELEASED BY LYMPHOCYTE ON TUMORIGENESIS IN MAN

1971 FEDERATION PROCEEDINGS 30(6):1858-& MERIGAN TC; STEVENS DA VIRAL INFECTIONS IN MAN ASSOCIATED WITH ACQUIRED IMMUNOLOGICAL DEFICIENCY STATES

1971 INFECTION AND IMMUNITY 4(5):575-80 BURGER DR; JETER WS CELL-FREE PASSIVE TRANSFER OF DELAYED HYPERSENSITIVITY TO CHEMICALS IN GUINEA PIGS

1971 JOURNAL OF CLINICAL INVESTIGATION 50(6):A71-& OETTGEN H; OLD L; FARROW J; VALENTIN.F; LAWRENCE S; THOMAS L EFFECTS OF TRANSFER FACTOR IN CANCER PATIENTS

1971 JOURNAL OF IMMUNOLOGY 107(6):1778-& GERY I; GERSHON RK; WAKSMAN BH POTENTIATION OF CULTURED MOUSE THYMOCYTE RESPONSES BY FACTORS RELEASED BY PERIPHERAL LEUCOCYTES

1971 LANCET 2(7719):293-& BRANDES LJ; GALTON DAG; WILTSHAW E NEW APPROACH TO IMMUNOTHERAPY OF MELANOMA

1971 LANCET 2(7719):297-& MACKLER BF ROLE OF SOLUBLE LYMPHOCYTE MEDIATORS IN MALIGNANT-TUMOUR DESTRUCTION

1971 LANCET 2(7730):898-& LEVY RL; BACH ML; HUANG SW; BACH FH; HONG R; AMMANN AJ; BORTIN M; KAY HEM THYMIC TRANSPLANTATION IN A CASE OF CHRONIC MUCOCUTANEOUS- CANDIDIASIS

1971 LANCET 2(7731):980-& HAVEMANN K; SODOMANN CP; HORVAT M NATURE OF MIF

1971 MEDICAL CLINICS OF NORTH AMERICA 55(3):761-& OETTGEN HF; OLD LJ; BOYSE EA HUMAN TUMOR IMMUNOLOGY

1971 MEDICAL JOURNAL OF AUSTRALIA 2(22):1102-& [ANON] IMMUNODEFICIENCIES IN CHILDREN

1971 NEW ENGLAND JOURNAL OF MEDICINE 285(6):324-& CRADDOCK CG; LONGMIRE R; MCMILLAN R LYMPHOCYTES AND IMMUNE RESPONSE .1.

1971 PEDIATRICS 47(5):927-& FUDENBER.H; GOOD RA; GOODMAN HC; HITZIG W; KUNKEL HG; ROITT IM; ROSEN FS; ROWE DS; SELIGMAN.M; SOOTHILL JR PRIMARY IMMUNODEFICIENCIES

1971 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 136(4):1385-& BURGER DR; COZINE WS; HINRICHS DJ PASSIVE TRANSFER OF CHEMICAL HYPERSENSITIVITIES IN RABBITS

1971 REVUE EUROPEENNE D ETUDES CLINIQUES ET BIOLOGIQUE 16(3):201-204 THOMPSON RB LYMPHOCYTE TRANSFER FACTOR

1971 SEMINARS IN HEMATOLOGY 8(3):192-& HUBER H; DOUGLAS SD FUNCTIONAL IMPAIRMENT OF LYMPHOCYTES AND MONOCYTES - ASSESSMENT IN-VITRO

1971 SEMINARS IN HEMATOLOGY 8(3):304-& FUNDENBE.HH HEMATOLOGY AND INFECTIONS - CONCLUSION

1971 UNION MEDICALE DU CANADA 100(1):117-& PRETTY HM RENAL TRANSPLANTATION - ACTUAL CONCEPTS OF IMMUNE RESPONSE

1971 UNION MEDICALE DU CANADA 100(6):1124-& JONCAS J VACCINES AND PROBLEMS SURROUNDING THEIR USE

1972 PROC AMER ASSOC CANC RES 118 RITZ RG ET AL CONVERSION OF LYMPHOID CELLS FROM PATIENTS WITH ACTIVE HODGKIN’S DISEASE TO PPD REACTIVITY WITH DIALYSABLE TRANSFER FACTOR

1972 AMERICAN JOURNAL OF PATHOLOGY 69(3):529-535 FUDENBER.HH; SPITLER LE; LEVIN AS TREATMENT OF IMMUNE DEFICIENCY

1972 ANNALS OF ALLERGY 30(10):562-& HILL JM; KHAN A IMMUNOLOGICAL PROBLEMS ENCOUNTERED IN HEMATOLOGY

1972 ANNALS OF INTERNAL MEDICINE 76(5):854-& LAWRENCE HS TRANSFER FACTOR AND CELLULAR IMMUNE DEFICIENCY DISEASES

1972 ANNALS OF INTERNAL MEDICINE 77(1):101-& STIEHM ER; CRADDOCK CG; FUDENBER.HH; AMMANN AJ; BARNETT EV; LAWLOR GJ DISEASES OF CELLULAR IMMUNITY

1972 ANNALS OF INTERNAL MEDICINE 77(4):605-& WALDMANN TA; STROBER W; BLAESE RM IMMUNODEFICIENCY DISEASE AND MALIGNANCY - VARIOUS IMMUNOLOGICAL DEFICIENCIES OF MAN AND ROLE OF IMMUNE PROCESSES IN CONTROL OF MALIGNANT DISEASE

1972 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 201(OCT27):437-& BALDINI MG NATURE OF PLATELET DEFECT IN WISKOTT-ALDRICH SYNDROME

1972 BRITISH MEDICAL JOURNAL 2(5811):442-& PABST HF; SWANSON R SUCCESSFUL TREATMENT OF CANDIDIASIS WITH TRANSFER FACTOR

1972 CALIFORNIA MEDICINE 116(4):19-& EDELSON PJ DIAGNOSIS OF IMMUNOLOGICAL DEFICIENCY IN CHILDHOOD

1972 CANCER RESEARCH 32(4):839-& DECKERS PJ; PILCH YH MEDIATION OF IMMUNITY TO TUMOR-SPECIFIC TRANSPLANTATION ANTIGENS BY RNA INHIBITION OF ISOGRAFT GROWTH IN RATS

1972 CELLULAR IMMUNOLOGY 3(4):R1-& GOOD RA TRANSFER FACTOR

1972 CELLULAR IMMUNOLOGY 3(4):606-& SCHULKIN.ML; ADLER WH; ALTEMEIE.WA; AYOUB EM TRANSFER FACTOR IN TREATMENT OF A CASE OF CHRONIC MUCOCUTANEOUS CANDIDIASIS

1972 EUROPEAN JOURNAL OF IMMUNOLOGY 2(6):546-550 MARSMAN AJW; VANDERHA.M; WALIG C; EIJSVOOG.VP MIGRATION INHIBITION EXPERIMENTS WITH MIXTURES OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES AND GUINEA-PIG PERITONEAL EXUDATE CELLS

1972 FEDERATION PROCEEDINGS 31(2):A754-& HOLZMAN RS; VALENTIN.FT; LAWRENCE HS FACTORS AFFECTING PRODUCTION AND ASSAY OF CLONING INHIBITION FACTOR

1972 INFECTION AND IMMUNITY 6(3):384-& SMITH RA; BIGLEY NJ DETECTION OF DELAYED-HYPERSENSITIVITY IN MICE INJECTED WITH RIBONUCLEIC ACID-PROTEIN FRACTIONS OF SALMONELLA-TYPHIMURIUM

1972 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 43(3):410-418 ARALACHA.MP; PINTO AS TRANSFER FACTOR WITH DINITROCHLOROBENZENE - SEVERAL REMARKS

1972 JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME A 54(7):1367-& MARSH B; ENNEKING W; FLYNN L IMMUNOLOGICAL ASPECTS OF OSTEOSARCOMA AND THEIR APPLICATION TO THERAPY - PRELIMINARY REPORT

1972 JOURNAL OF CLINICAL INVESTIGATION 51(11):2948-58 KIRKPATRICK CH; SMITH TK; RICH RR EFFECT OF TRANSFER FACTOR ON LYMPHOCYTE FUNCTION IN ANERGIC PATIENTS 1972 JOURNAL OF CLINICAL INVESTIGATION 51(12):3216-& SPITLER LE; STITES DP; STIEHM ER; AUGUST CS; PIROFSKY B; HITZIG WH; GATTI RA; FUDENBER.HH; LEVIN AS WISKOTT-ALDRICH SYNDROME - RESULTS OF TRANSFER FACTOR THERAPY

1972 JOURNAL OF EXPERIMENTAL MEDICINE 136(1):156-& SPITLER LE; VONMULLE.CM; FUDENBER.HH; EYLAR EH EXPERIMENTAL ALLERGIC ENCEPHALITIS - DISSOCIATION OF CELLULAR IMMUNITY TO BRAIN PROTEIN AND DISEASE PRODUCTION

1972 JOURNAL OF IMMUNOLOGY 108(6):1597-& RUBIN AS; COONS AH SPECIFIC HETEROLOGOUS ENHANCEMENT OF IMMUNE-RESPONSES .3. PARTIAL CHARACTERIZATION OF SUPERNATANT MATERIAL WITH ENHANCING ACTIVITY

1972 LANCET 1(7742):120-& BECKER FW; DEICHER H; KRULL P; KALDEN JR LEUCOCYTE-MIGRATION TEST IN SARCOIDOSIS

1972 LANCET 1(7748):469-& VALDIMAR.H; HOLT PJL; HOBBS JR; MOSS PD TREATMENT OF CHRONIC MUCOCUTANEOUS CANDIDIASIS WITH LEUKOCYTES FROM HL-A COMPATIBLE SIBLING

1972 MEDICAL CLINICS OF NORTH AMERICA 56(2):465-& MARSHALL WH TRANSFER OF IMMUNE RESPONSIVENESS

1972 MEDICAL CLINICS OF NORTH AMERICA 56(3):801-& CINADER B FUTURE OF TUMOR IMMUNOLOGY

1972 MONATSSCHRIFT KINDERHEILKUNDE 120(6):246-& GROB PJ CLASSIFICATION OF IMMUNOSUPPRESSIVE DRUGS ACCORDING TO THEIR CLINICAL APPLICATION

1972 NEW ENGLAND JOURNAL OF MEDICINE 286(15):797-& STIEHM ER; SENGAR DPS; TERASAKI PI; GREENWAL.HL; NEERHOUT RC; LAWLOR GJ; KAPLAN MS IMMUNOLOGICAL RECONSTITUTION IN SEVERE COMBINED IMMUNODEFICIENCY WITHOUT BONE-MARROW CHROMOSOMAL CHIMERISM

1972 NEW ENGLAND JOURNAL OF MEDICINE 287(21):1092-94 LAWRENCE HS IMMUNOTHERAPY WITH TRANSFER FACTOR

1972 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 69(4):1026-& GOOD RA RELATIONS BETWEEN IMMUNITY AND MALIGNANCY

1972 PROGRESS IN ALLERGY 16():300-& DAVID JR; DAVID RR CELLULAR HYPERSENSITIVITY AND IMMUNITY - INHIBITION OF MACROPHAGE MIGRATION AND LYMPHOCYTE MEDIATORS

1972 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 102(33):1188-& MAYLEVIN F; BRULE G; GRAFFTE G USE OF SOLUBLE FACTORS PRODUCED BY LYMPHOCYTES AS A THERAPEUTIC ADJUVANT IN METASTASIZING TUMORS

1972 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 102(35):1237-& HITZIG WH; FUDENBER.HH; MUNTENER U; PAUL S; FONTANEL.HP; SPITLER LE TRANSFER FACTOR

1972 SCIENCE 175(4029):1473-& BURGER DR; VETTO RM; MALLEY A TRANSFER FACTOR FROM GUINEA-PIGS SENSITIVE TO DINITROCHLOROBENZENE - ABSENCE OF SUPERANTIGEN PROPERTIES

1972 SCIENCE 178(4062):757-& MADDISON SE; HICKLIN MD; CONWAY BP; KAGAN IG TRANSFER FACTOR - DELAYED-HYPERSENSITIVITY TO SCHISTOSOMA- MANSONI AND TUBERCULIN IN MACACA-MULATTA

1972 SEMAINE DES HOPITAUX 48(42):2717-& DRYLL A; SEZE SD HUMORAL MEDIATORS OF DELAYED CELL IMMUNITY

1972 SEMINARS IN HEMATOLOGY 9(2):181-& BERNARD J; WEIL M; JACQUILL.C TREATMENT OF ACUTE LEUKEMIAS

1972 TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 66(6):955-956 BRAY RS; WILSON VCL LACK OF TRANSFER FACTOR IN GUINEA-PIG LEISHMANIASIS

1972 TRANSPLANTATION 13(3):229-& DYMINSKI JW; ARGYRIS BF IN-VITRO SENSITIZATION TO TRANSPLANTATION ANTIGENS .2. ROLE OF H-2 ANTIGEN AND CULTURE SUPERNATANT

1972 TRANSPLANTATION 14(6):689-& HALTERMA.RH; GRAW RG; LEVENTHA.BG; FUCCILLO DA IMMUNOCOMPETENCE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MAN

1973 THE LANCET I: 434 SMITH RA ET AL LAWRENCE TRANSFER FACTOR AND HODGKIN’S DISEASE

1973 AMERICAN JOURNAL OF THE MEDICAL SCIENCES 266(5):359-369 MIZEJEWS.GJ HUMORAL RESPONSES IN TUMOR IMMUNITY - REVIEW OF EXPERIMENTAL FINDINGS

1973 ANNALS OF INTERNAL MEDICINE 79(2):161-166 WHITCOMB ME; ROCKLIN RE TRANSFER FACTOR THERAPY IN A PATIENT WITH PROGRESSIVE PRIMARY TUBERCULOSIS

1973 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 207(MAY31):29-48 TALMAGE DW; RADOVICH J; LEFEVER J; HEMMINGS.H ROLE OF AUXILIARY (NOT ANTIGEN-SPECIFIC) CELLS IN PRODUCTION OF THYMUS-DEPENDENT MEDIATORS - 3 UNIVERSES OF PREPROGRAMMED CLONES

1973 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 207(MAY31):352-354 BLOOM BR TRANSFER FACTOR(S) AND DELAYED-TYPE HYPERSENSITIVITY - INTRODUCTION

1973 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 207(MAY31):406-407 JETER WS SUBCELLULAR TRANSFER OF ACTIVITY - DISCUSSION

1973 ANNUAL REVIEW OF MEDICINE 24():135-144 BIGGAR WD; PARK BH; GOOD RA IMMUNOLOGICAL RECONSTITUTION

1973 ANNUAL REVIEW OF MEDICINE 24():175-208 LEVIN AS; SPITLER LE; FUDENBER.HH TRANSFER FACTOR THERAPY IN IMMUNE DEFICIENCY STATES

1973 ARCHIVES OF DERMATOLOGY 108(2):259-262 KROLL JJ; EINBINDE.JM; MERZ WG MUCOCUTANEOUS CANDIDIASIS IN A MOTHER AND SON

1973 BIOMEDICINE 18(3):220-227 GRISCELL.C; REVILLAR.JP; BETUEL H; HERZOG C; TOURAINE JL TRANSFER FACTOR THERAPY IN IMMUNO-DEFICIENCIES

1973 BLUT 27(3):145-150 HITZIG WH TRANSFER FACTOR AND ITS THERAPEUTIC IMPORTANCE

1973 BRITISH JOURNAL OF DERMATOLOGY 89(2):179-190 HIGGS JM; WELLS RS CHRONIC MUCO-CUTANEOUS CANDIDIASIS - NEW APPROACHES TO TREATMENT

1973 CALIFORNIA MEDICINE 118(2):47-47 SPITLER LE CLINICAL USES OF TRANSFER FACTOR

1973 CELLULAR IMMUNOLOGY 6(3):331-347 BLOOM BR; CEPPELLI.R; CEROTTIN.JC; DAVID JR; KUNKEL H; LANDY M; LAWRENCE HS; MAINI R; NUSSENZW.V; PERLMANN P; SPITLER L; ROSEN F; ZABRISKI.J IN-VITRO METHODS IN CELL-MEDIATED IMMUNITY - PROGRESS REPORT

1973 CELLULAR IMMUNOLOGY 6(3):368-374 PAQUE RE; DRAY S; KNISKERN P; BARAM P IN-VITRO STUDIES WITH TRANSFER-FACTOR .2. TRANSFER OF CELL- MIGRATION INHIBITION CORRELATE OF DELAYED-HYPERSENSITIVITY IN HUMANS WITH NONDIALYZABLE COMPONENTS OF LEUKOCYTE LYSATES FROM HUMANS SENSITIZED TO HISTOPLASMIN AND COCCIDIOIDIN

1973 CELLULAR IMMUNOLOGY 7(1):159-165 LOBUGLIO AF; NEIDHART JA; HILBERG RW; METZ EN; BALCERZA.SP EFFECT OF TRANSFER FACTOR THERAPY ON TUMOR IMMUNITY IN ALVEOLAR SOFT PART SARCOMA

1973 CELLULAR IMMUNOLOGY 7(2):222-236 WEISSMAN I; LANNIN D; JERABEK L; BARCLAY T CELLULAR IMMUNITY TO HETEROLOGOUS ERYTHROCYTES IN-VITRO .1. ROLE OF SURFACE-ADHERENT CELLS AND SPECIFIC MEDIATORS IN AN EFFECTOR MECHANISM

1973 CELLULAR IMMUNOLOGY 8(1):120-135 GRAYBILL JR; SILVA J; ALFORD RH; THOR DE IMMUNOLOGICAL AND CLINICAL IMPROVEMENT OF PROGRESSIVE COCCIDIOIDOMYCOSIS FOLLOWING ADMINISTRATION OF TRANSFER FACTOR

1973 CELLULAR IMMUNOLOGY 8(1):147-154 BURGER DR; LILLEY DP; REID M; IRISH L; VETTO RM ALPHA GLOBULIN CHANGES DURING DEVELOPMENT OF CELLULAR IMMUNITY

1973 CELLULAR IMMUNOLOGY 8(2):249-258 HOLZMAN RS; LEBOWITZ AS; VALENTIN.FT; LAWRENCE HS PREPARATION AND PROPERTIES OF CLONING INHIBITORY FACTOR .1. INHIBITION OF HELA-CELL CLONING BY STIMULATED LYMPHOCYTES AND THEIR CULTURE SUPERNATANTS

1973 CELLULAR IMMUNOLOGY 8(2):259-269 HOLZMAN RS; VALENTIN.FT; LAWRENCE HS PREPARATION AND PROPERTIES OF CLONING INHIBITORY FACTOR .2. FACTORS AFFECTING ITS PRODUCTION AND ASSAY

1973 CELLULAR IMMUNOLOGY 9(2):297-305 GOLDBLUM RM; LORD RA; DUPREE E; WEINBERG AG; GOLDMAN AS TRANSFER FACTOR INDUCED DELAYED-HYPERSENSITIVITY IN X-LINKED COMBINED IMMUNODEFICIENCY

1973 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 14(2):213-217 HAN T IMMUNE RNA-MEDIATED TRANSFER OF DELAYED SKIN REACTIVITY IN PATIENTS WITH HODGKINS-DISEASE

1973 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 15(1):87-92 SILVA C; LIMA AO; ANDRADE LMC; MATTOS O ATTEMPTS TO CONVERT LEPROMATOUS INTO TUBERCULOID-TYPE LEPROSY WITH BLOOD LYMPHOCYTE EXTRACTS FROM SENSITIZED DONORS

1973 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 1(4):429-445 PROVOST TT; GARRETTS.LK; ZESCHKE RH; ROSE NR; TOMASI TB COMBINED IMMUNE DEFICIENCY, AUTOANTIBODY FORMATION, AND MUCOCUTANEOUS CANDIDIASIS

1973 CLINICAL PEDIATRICS 12(9):529-537 MADDISON SE DELAYED-HYPERSENSITIVITY AND CELL-MEDIATED IMMUNITY - SURVEY OF CURRENT INSIGHTS INTO THESE RESPONSES OF BODY TO ANTIGENS

1973 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 98(9):415-420 BLAKER F; GROB PJ; HELLWEGE HH; SCHULZ KH IMMUNOLOGICAL DEFENCE AND TRANSFER FACTOR THERAPY IN CHRONIC MUCOCUTANEOUS CANDIDIASIS

1973 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 98(9):446-451 GROB PJ; BLAKER F; SCHULZ KH IMMUNE FUNCTION AND TRANSFER FACTOR

1973 INFECTION AND IMMUNITY 7(2):226-230 SINSKI JT; REED GL; KELLEY LM; LEFEBVRE R MACROPHAGE MIGRATION TECHNIQUE USING COCCIDIOIDIN

1973 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 45(1-2):322-325 MARSMAN AJW; VANDERHA.M MIGRATION INHIBITION EXPERIMENTS WITH MIXTURES OF HUMAN LYMPHOCYTES AND GUINEA-PIG PERITONEAL EXUDATE CELLS

1973 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 51(5):296-302 KIRKPATR.CH; MEEK JC; RICH RR MECHANISM OF ALLERGY TO COMPONENTS OF COMMERCIAL BOVINE THYROTROPIN

1973 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 52(1):1-12 FACKTOR MA; BERNSTEI.RA; FIREMAN P HYPERSENSITIVITY TO TETANUS TOXOID

1973 JOURNAL OF IMMUNOLOGY 110(1):219-226 SAGER MA; LAWTON JWM; MURPHY WH SERUM TRANSMISSIBILITY OF IMMUNE POLIOENCEPHALOMYELITIS IN C58 MICE

1973 JOURNAL OF INVESTIGATIVE DERMATOLOGY 60(6):522-528 MAUER AM X-LINKED RECESSIVE DISORDERS - CHRONIC GRANULOMATOUS DISEASE AND WISKOTT-ALDRICH SYNDROME

1973 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 81(4):538-548 BLAESE RM; WEIDEN P; OPPENHEI.JJ; WALDMANN TA PHYTOHEMAGGLUTININ AS A SKIN-TEST FOR EVALUATION OF CELLULAR IMMUNE COMPETENCE IN MAN

1973 JOURNAL OF PEDIATRICS 83(5):772-780 BALLOW M; DUPONT B; GOOD RA AUTOIMMUNE HEMOLYTIC-ANEMIA IN WISKOTT-ALDRICH SYNDROME DURING TREATMENT WITH TRANSFER FACTOR

1973 KLINISCHE PADIATRIE 185(5):335-338 OEHME J; GUTZEIT D LYMPHOCYTES

1973 LANCET 2(7820):79-81 [ANON] TRANSFER FACTOR

1973 LANCET 2(7833):822-823 GOTTLIEB AA; FOSTER LG; WALDMAN SR; LOPEZ M WHAT IS TRANSFER FACTOR

1973 LANCET 2(7834):914-915 FUDENBER.HH TRANSFER FACTOR

1973 LANCET 2(7842):1382-1382 EMODI G; JUST M; GROB P CIRCULATING INTERFERON AFTER TRANSFER-FACTOR THERAPY

1973 MEDICAL CLINICS OF NORTH AMERICA 57(2):441-461 GRAW RG; YANKEE RA PRINCIPLES OF HEMATOLOGIC SUPPORTIVE CARE

1973 MEDICAL CLINICS OF NORTH AMERICA 57(5):1277-1287 DALE DC; PETERSDO.RG CORTICOSTEROIDS AND INFECTIOUS DISEASES

1973 NEW ENGLAND JOURNAL OF MEDICINE 288(3):143-149 DAVID JR; HENSHAW E; HIRSCH C LYMPHOCYTE MEDIATORS AND CELLULAR HYPERSENSITIVITY

1973 NEW ENGLAND JOURNAL OF MEDICINE 288(14):710-713 WYBRAN J; LEVIN AS; SPITLER LE; FUDENBER.HH ROSETTE-FORMING CELLS, IMMUNOLOGICAL DEFICIENCY DISEASES AND TRANSFER FACTOR

1973 NEW ENGLAND JOURNAL OF MEDICINE 288(14):740-741 ENGLISH DK TRANSFER FACTOR AND LEPROMATOUS LEPROSY

1973 NEW ENGLAND JOURNAL OF MEDICINE 288(17):908-909 BLOOM BR DOES TRANSFER FACTOR ACT SPECIFICALLY OR AS AN IMMUNOLOGICAL ADJUVANT

1973 NEW ENGLAND JOURNAL OF MEDICINE 288(20):1072-1073 WYBRAN J; FUDENBER.HH THYMUS-DERIVED ROSETTE-FORMING CELLS

1973 NEW ENGLAND JOURNAL OF MEDICINE 289(5):272-272 GOTTLIEB AA NATURE OF TRANSFER FACTOR

1973 NOUVELLE PRESSE MEDICALE 2(20):1341-1344 MOULIAS R; GOUST JM; REINERT P; FOURNEL JJ; DEVILLEC.A; DUONG N; MULLERBE.CN; BERTHAUX P TRANSFER FACTOR OF CELL MEDIATED IMMUNITY

1973 NOUVELLE PRESSE MEDICALE 2(34):2271-2273 WEILL B RECENT WORK ON IMMUNE DEFICIENCIES IN MAN

1973 NOUVELLE REVUE FRANCAISE D HEMATOLOGIE 13(4):554-568 GRISCELL.C; TRUNG PH; HERZOG C; MOZZICON.P WISKOTT-ALDRICHS SYNDROME

1973 PATHOLOGIE BIOLOGIE 21(3):285-& LANG JM IMMUNOLOGICAL COMPETENCE IN HODGKINS-DISEASE

1973 PROCEEDINGS OF AN INTERNATIONAL SYMPOSIUM ON CALCIFIED TISSUES DENTAL AND SURGICAL MATERIALS AND TISSUE MATERIAL INTERACTIONS ():231-243 STITES DP; CARR MC; FUDENBER.HH SEGREGATION OF IN-VITRO CELLULAR IMMUNE FUNCTIONS IN LYMPHOID ORGANS DURING EARLY HUMAN FETAL DEVELOPMENT

1973 PROGRESS IN ALLERGY 17():227-299 BAKER MA; TAUB RN IMMUNOTHERAPY OF HUMAN CANCER

1973 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2(4):367-374 VANDVIK B; FROLAND SS; HOYERAAL HM; STIEN R; DEGRE M IMMUNOLOGICAL FEATURES IN A CASE OF SUBACUTE SCLEROSING PANENCEPHALITIS TREATED WITH TRANSFER FACTOR

1973 SURGERY 74(1):59-68 SMITH GV; MORSE PA; DERAPS GD; RAJU S; HARDY JD IMMUNOTHERAPY OF PATIENTS WITH CANCER

1973 TRANSPLANTATION PROCEEDINGS 5(1):49-58 LAWRENCE HS MEDIATORS OF CELLULAR IMMUNITY

1973 TRANSPLANTATION REVIEWS 16():196-217 BACH JF EVALUATION OF T-CELLS AND THYMIC SERUM FACTORS IN MAN USING ROSETTE TECHNIQUE

1973 WIENER KLINISCHE WOCHENSCHRIFT 85(20):357-360 MUTZ I; HUMPHREY GB BIOLOGICAL AND CLINICAL IMPLICATIONS OF TRANSFER FACTOR

1973 ZEITSCHRIFT FUR IMMUNITATS-FORSCHUNG EXPERIMENTELLE UND KLINISCHE IMMUNOLOGIE 146(2):93-100 HERMAN PS TRANSFER FACTOR IN SALICYLANILIDE CONTACT ALLERGY 1977 ACTA ALLERGOLOGICA 32(4):236-247 THULIN H; ELLEGAARD J; THESTRUPPEDERSEN K; ZACHARIAE H LONG-TERM TRANSFER-FACTOR TREATMENT IN SEVERE ATOPIC-DERMATITIS

1974 THE HARVEY LECTURES 68: 239-350 LAWRENCE HS TRANSFER FACTOR IN CELLULAR IMMUNITY

1974 PROC R SOC MED 67: 597-8 MORISON WL EFFECT OF MITOGENS ON LEUKOCYTE MIGRATION INHIBITION TEST IN IMMUNE DEFICIENCY STATES AND INFLUENCE OF TRANSFER FACTOR ON RESPONSE

1974 ACTA ALLERGOLOGICA 29(2):101-116 THESTRUP.K; THULIN H; ZACHARIA.H TRANSFER-FACTOR APPLIED TO INTENSIFY CELL-MEDIATED IMMUNOLOGICAL REACTIONS AGAINST MYCOBACTERIUM-AVIUM

1974 ACTA VETERINARIA ACADEMIAE SCIENTIARUM HUNGARICAE 24(1-2):1-6 TUBOLY S; SZANTO T; RADY M TUBERCULIN SENSITIVITY OF SENSITIZED LYMPHOCYTES

1974 AMERICAN JOURNAL OF CLINICAL NUTRITION 27(6):647-664 COOPER WC; GOOD RA; MARIANI T EFFECTS OF PROTEIN INSUFFICIENCY ON IMMUNE RESPONSIVENESS

1974 AMERICAN JOURNAL OF CLINICAL PATHOLOGY 62(2):184-211 PILCH YH; GOLUB SH LYMPHOCYTE-MEDIATED IMMUNE-RESPONSES IN NEOPLASIA

1974 AMERICAN JOURNAL OF CLINICAL PATHOLOGY 62(2):224-242 SOUTHAM CM AREAS OF RELATIONSHIP BETWEEN IMMUNOLOGY AND CLINICAL ONCOLOGY

1974 AMERICAN JOURNAL OF DISEASES OF CHILDREN 128(5):739-742 FLEISHER TA; KERSEY JH IMMUNOLOGICAL MECHANISMS IN PREVENTION AND THERAPY OF CANCER

1974 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 119(7):959-965 VELTMAN LL; KERN DH; PILCH YH IMMUNE CYTOLYSIS OF HUMAN TUMOR-CELLS MEDIATED BY XENOGENEIC IMMUNE RIBONUCLEIC-ACID - IMPLICATIONS FOR IMMUNOTHERAPY

1974 AMERICAN JOURNAL OF PATHOLOGY 74(2):365-376 UGRINSKI PS; KIRKPATR.CH CORNEAL CELLULAR IMMUNITY IN GUINEA-PIG

1974 ANNALS OF ALLERGY 33(6):337-343 SWINEFOR.O ALLERGY VERSUS CLINICAL IMMUNOLOGY - CRITICAL ANALYSIS

1974 ANNALS OF INTERNAL MEDICINE 80(3):310-320 KIRKPATR.CH; SMITH TK CHRONIC MUCOCUTANEOUS CANDIDIASIS - IMMUNOLOGICAL AND ANTIBIOTIC THERAPY

1974 ANNALS OF INTERNAL MEDICINE 80(6):685-692 EDELSON RL; KIRKPATR.CH; SHEVACH EM; SCHEIN PS; SMITH RW; GREEN I; LUTZNER M PREFERENTIAL CUTANEOUS INFILTRATION BY NEOPLASTIC THYMUS- DERIVED LYMPHOCYTES - MORPHOLOGIC AND FUNCTIONAL STUDIES

1974 ANNALS OF INTERNAL MEDICINE 80(6):764-767 WYBRAN J; FUDENBER.H HOW CLINICALLY USEFUL IS T AND B-CELL QUANTITATION

1974 ANNALS OF INTERNAL MEDICINE 81(6):838-847 POTTER H; ROSENFEL.S; DRESSLER D TRANSFER FACTOR

1974 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 221(FEB28):317-323 VALENTIN. FT SOLUBLE FACTORS PRODUCED BY LYMPHOCYTES

1974 ARCHIVES OF DERMATOLOGY 110(3):375-377 LUCKASEN JR; SABAD A; GOLTZ RW; KERSEY JH T AND B LYMPHOCYTES IN ATOPIC ECZEMA

1974 ARCHIVES OF OPHTHALMOLOGY 92(4):335-339 WONG VG; KIRKPATR.CH IMMUNE RECONSTITUTION IN KERATOCONJUNCTIVITIS AND SUPERFICIAL CANDIDIASIS - ROLE OF IMMUNOCOMPETENT LYMPHOCYTE TRANSFUSION AND TRANSFER-FACTOR

1974 AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 4(4):396-411 WELLS JV; FUDENBER.HH MANAGEMENT OF PATIENTS WITH PRIMARY IMMUNE DEFICIENCY SYNDROMES

1974 AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 4(6):585-596 COOPER DA; PENNY R BEHCETS SYNDROME - CLINICAL, IMMUNOLOGICAL AND THERAPEUTIC EVALUATION OF 17 PATIENTS

1974 AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY 44(4):321-329 STEPHENS FO TUMOR IMMUNOLOGY - REVIEW OF PRESENT SITUATION WITH PARTICULAR REFERENCE TO SOLID TUMORS AND SURGICAL IMPLICATIONS

1974 AUSTRALIAN PAEDIATRIC JOURNAL 10(1):1-9 JOSE DG MECHANISMS OF IMMUNE DEFENCE

1974 AUSTRALIAN PAEDIATRIC JOURNAL 10(3):113-& JOSE DG IMMUNOBIOLOGY OF CHILDHOOD DISEASES

1974 BRITISH MEDICAL JOURNAL 2(5916):397-398 [ANON] TRANSFER-FACTOR

1974 CANCER 33(2):394-401 KREMENTZ ET; MANSELL PWA; HORNUNG MO; SAMUELS MS; SUTHERLA.CA; BENES EN IMMUNOTHERAPY OF MALIGNANT DISEASE - USE OF VIABLE SENSITIZED LYMPHOCYTES OR TRANSFER-FACTOR PREPARED FROM SENSITIZED LYMPHOCYTES

1974 CANCER 33(2):497-502 HAN T TRANSFER OF CELL-MEDIATED SKIN REACTIVITY WITH IMMUNE RNA IN HODGKINS-DISEASE AND OTHER NEOPLASTIC DISEASES

1974 CANCER 34(4):1521-1531 MCKHANN CF; GUNNARSS.A APPROACHES TO IMMUNOTHERAPY

1974 CANCER 34(4):1563-1570 LOBUGLIO AF; NEIDHART JA REVIEW OF TRANSFER-FACTOR IMMUNOTHERAPY IN CANCER

1974 CANCER 34(6):2014-2017 PAPATESTAS AE; KARK AE PERIPHERAL LYMPHOCYTE COUNTS IN BREAST CARCINOMA - INDEX OF IMMUNE COMPETENCE

1974 CANCER CHEMOTHERAPY REPORTS PART 1 58(4):571-578 MERIGAN TC INTERFERON - ITS INDUCERS AND SOME ASPECTS OF HOST RESISTANCE IN MALIGNANCY

1974 CANCER RESEARCH 34(11):3095-3101 BRANDES LJ; GOLDENBE.GJ INVITRO TRANSFER OF CELLULAR IMMUNITY AGAINST NASOPHARYNGEAL CARCINOMA USING TRANSFER-FACTOR FROM DONORS WITH EPSTEIN-BARR VIRUS-ANTIBODY ACTIVITY

1974 CELLULAR IMMUNOLOGY 10(1):68-77 KIRCHNER H; ALTMAN LC; FRIDBERG AP; OPPENHEI.JJ DISSOCIATION OF IN-VITRO LYMPHOCYTE-TRANSFORMATION FROM PRODUCTION OF A MONONUCLEAR LEUKOCYTE CHEMOTACTIC FACTOR IN AGAMMAGLOBULINEMIC CHICKENS

1974 CELLULAR IMMUNOLOGY 10(1):86-104 GEHA RS; MERLER E HUMAN LYMPHOCYTE MITOGENIC FACTOR - SYNTHESIS BY SENSITIZED THYMUS-DERIVED LYMPHOCYTES, DEPENDENCE OF EXPRESSION ON PRESENCE OF ANTIGEN

1974 CELLULAR IMMUNOLOGY 10(3):338-343 HORSMANH.M LYMPHOCYTE TRANSFORMING FACTOR IN SARCOIDOSIS

1974 CELLULAR IMMUNOLOGY 10(3):371-379 ARALACHA.MP; PROENCA R; DESOUSA M TRANSFER-FACTOR THERAPY IN A CASE OF COMPLEX IMMUNODEFICIENCY

1974 CELLULAR IMMUNOLOGY 10(3):432-441 BURGER DR; LILLEY DP; VETTO RM LYMPHOCYTE SUPPRESSION ASSOCIATED WITH ALPHA-GLOBULIN CHANGES IN CELLULAR IMMUNITY

1974 CELLULAR IMMUNOLOGY 12(1):37-48 STEVENS DA; PAPPAGIA.D; MARINKOV.VA; WADDELL TF IMMUNOTHERAPY IN RECURRENT COCCIDIOIDOMYCOSIS

1974 CELLULAR IMMUNOLOGY 12(1):94-101 AMMANN AJ; WARA D; SALMON S TRANSFER-FACTOR - THERAPY IN PATIENTS WITH DEFICIENT CELL- MEDIATED-IMMUNITY AND DEFICIENT ANTIBODY-MEDIATED IMMUNITY

1974 CELLULAR IMMUNOLOGY 12(1):160-163 ARALACHA.M; RAMOS MTF; ROSADO RMF EVIDENCE FOR PROMPT AND INTENSE RECONSTITUTION OF CELL- MEDIATED-IMMUNITY BY MEANS OF TRANSFER-FACTOR IN A CASE OF COMPLEX IMMUNE DEFICIENCY

1974 CELLULAR IMMUNOLOGY 12(3):481-486 LIPSMEYE.EA RAPID METHOD FOR MEASURING PRODUCTION OF HUMAN MIGRATION- INHIBITORY FACTOR (MIF)

1974 CELLULAR IMMUNOLOGY 13(2):196-206 PALMER DW; SMITH RT AUGMENTATION OF PPD-INDUCED AND LPS-INDUCED T-INDEPENDENT DNA- SYNTHESIS IN NORMAL MOUSE SPLEEN-CELLS BY LEUKOCYTE LYSATES FROM TUBERCULOSIS PATIENTS

1974 CELLULAR IMMUNOLOGY 14(1):12-21 GRAYBILL JR; ALFORD RH CELL-MEDIATED-IMMUNITY IN CRYPTOCOCCOSIS

1974 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 16(2):141-151 VALDIMAR.H; HAMBLETO.G; HENRY K; MCCONNEL.I RESTORATION OF T-LYMPHOCYTE DEFICIENCY WITH DIALYZABLE LEUKOCYTE EXTRACT

1974 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 17(1):43-49 BIBERFEL.G CELL-MEDIATED IMMUNE-RESPONSE FOLLOWING MYCOPLASMA-PNEUMONIAE INFECTION IN MAN .2. LEUKOCYTE MIGRATION-INHIBITION

1974 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 18(1):81-87 NATH I; CURTIS J; BHUTANI LK; TALWAR GP REDUCTION OF A SUBPOPULATION OF T-LYMPHOCYTES IN LEPROMATOUS LEPROSY

1974 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 2(3):301-309 KAY MM; BELOHRAD.B; YEE K; VOGEL J; BUTCHER D; WYBRAN J; FUDENBER.HH CELLULAR INTERACTIONS - SCANNING ELECTRON-MICROSCOPY OF HUMAN THYMUS-DERIVED ROSETTE-FORMING LYMPHOCYTES

1974 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 2(3):416-445 COOPER MD; FAULK WP; FUDENBER.HH; GOOD RA; HITZIG W; KUNKEL HG; ROITT IM; ROSEN FS; SELIGMAN.M; SOOTHILL JF; WEDGWOOD RJ MEETING REPORT OF SECOND INTERNATIONAL WORKSHOP ON PRIMARY IMMUNODEFICIENCY DISEASES IN MAN - HELD IN ST PETERSBURG, FLORIDA, FEBRUARY, 1973

1974 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 99(5):203-210 HAFERKAM.O DEFENSELESS ORGANISM

1974 HOSPITAL PRACTICE 9(1):95-104 FUDENBER.HH; LEVIN AS; SPITLER LE; WYBRAN J; BYERS V THERAPEUTIC USES OF TRANSFER FACTOR

1974 IMMUNOLOGY 26(6):1069-1080 SALAMAN MR STUDIES ON TRANSFER-FACTOR OF DELAYED-HYPERSENSITIVITY - EFFECT OF DIALYZABLE LEUKOCYTE EXTRACTS FROM PEOPLE OF KNOWN TUBERCULIN SENSITIVITY ON MIGRATION OF NORMAL GUINEA-PIG MACROPHAGES IN PRESENCE OF ANTIGEN

1974 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 46(4):612-618 ARALACHA.M; RAMOS MTF; ROSADO R; BRANCO P TRANSFER-FACTOR INVITRO - ADDITIONAL DATA CONCERNING A NEW METHOD

1974 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 47(5):665-680 LINDHOLM L GRAFT VERSUS HOST REACTIONS AND ACTIVATION OF HOST ANTIBODY- FORMING-CELLS INDUCED BY INVITRO STIMULATED SYNGENEIC LYMPHOCYTES

1974 INTERNATIONAL JOURNAL OF CANCER 14(3):401-416 LIEBERMA.R; EPSTEIN W; FUDENBER.HH IMMUNOPATHOLOGIC CHANGES IN PATIENTS WITH CUTANEOUS MALIGNANT- MELANOMA FOLLOWING INTRATUMORAL INOCULATION OF BCG - CORRELATION WITH CELL-MEDIATED-IMMUNITY

1974 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 42(4):507-508 JACOBSON RR; HASTINGS RC; MORALES MJ; SLACK CE TREATMENT OF LEPROSY WITH TRANSFER-FACTOR

1974 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 53(4):223-229 MENDES E; RAPHAEL A; MOTA NGS; MENDES NF CELL-MEDIATED-IMMUNITY IN LEPROSY AND TRANSFER OF DELAYED- HYPERSENSITIVITY REACTIONS

1974 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 54(1):1-13 BURNET FM TRANSFER-FACTOR - THEORETICAL DISCUSSION

1974 JOURNAL OF CLINICAL INVESTIGATION 54(3):690-701 CATANZAR.A; SPITLER L; MOSER KM IMMUNOTHERAPY OF COCCIDIOIDOMYCOSIS

1974 JOURNAL OF CLINICAL INVESTIGATION 54(4):997-1000 ZUCKERMA.KS; NEIDHART JA; BALCERZA.SP; LOBUGLIO AF IMMUNOLOGICAL SPECIFICITY OF TRANSFER-FACTOR

1974 JOURNAL OF IMMUNOLOGICAL METHODS 4(1):41-45 PANG GTM; BAGULEY DM; WILSON JD SPONTANEOUS ROSETTES AS A T-LYMPHOCYTE MARKER - MODIFIED METHOD GIVING CONSISTENT RESULTS - SRBC ROSETTES

1974 JOURNAL OF IMMUNOLOGICAL METHODS 6(1-2):1-22 PEKAREK J; KREJCI J SURVEY OF METHODOLOGICAL APPROACHES TO STUDYING DELAYED- HYPERSENSITIVITY INVITRO

1974 JOURNAL OF IMMUNOLOGY 112(1):376-386 SCHIFF RI; BUCKLEY RH; GILBERTS.RB; METZGAR RS MEMBRANE RECEPTORS AND IN-VITRO RESPONSIVENESS OF LYMPHOCYTES IN HUMAN IMMUNODEFICIENCY

1974 JOURNAL OF OBSTETRICS & GYNAECOLOGY OF THE BRITISH COMMONWEALTH 81(10):812-817 GROB PJ; WUTHRICH B TRANSFER-FACTOR THERAPY IN A PATIENT WITH CHRONIC VAGINAL CANDIDIASIS

1974 JOURNAL OF PEDIATRICS 84(5):681-688 PACHMAN LM; KIRKPATR.CH; KAUFMAN DH; ROTHBERG RM LACK OF EFFECT OF TRANSFER-FACTOR IN THYMIC DYSPLASIA WITH IMMUNOGLOBULIN-SYNTHESIS

1974 JOURNAL OF PEDIATRICS 84(6):789-796 KERSEY JH; GAJLPECZ.KJ; NESBIT ME LYMPHOID SYSTEMS - ABNORMALITIES IN IMMUNODEFICIENCY AND MALIGNANCY

1974 JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY 16(1):37-47 SCHULTZ RM; WOAN MC; TOMPKINS WA MACROPHAGE IMMUNITY TO VACCINA-VIRUS - FACTORS AFFECTING MACROPHAGE IMMUNITY INVITRO

1974 LABORATORY INVESTIGATION 31(1):60-67 HAASZ R; ALGOM D; RICHTER M CELLS INVOLVED IN CELL-MEDIATED AND TRANSPLANTATION IMMUNITY IN RABBIT .7. ORGAN SOURCE(S) OF CELLS OF SENSITIZED RABBIT CAPABLE OF TRANSFERRING DELAYED-HYPERSENSITIVITY STATE TO ALLOGENEIC RABBITS

1974 MAYO CLINIC PROCEEDINGS 49(7):455-459 DIAZBUXO JA; HERMANS PE; RITTS RE WISKOTT-ALDRICH SYNDROME IN AN ADULT

1974 MEDICINE 53(4):255-293 BODE FR; PARE JAP; FRASER RG PULMONARY-DISEASES IN COMPROMISED HOST - REVIEW OF CLINICAL AND ROENTGENOGRAPHIC MANIFESTATIONS IN PATIENTS WITH IMPAIRED HOST DEFENSE-MECHANISMS

1974 NEW ENGLAND JOURNAL OF MEDICINE 290(6):320-323 BENNETT JE DRUG-THERAPY - CHEMOTHERAPY OF SYSTEMIC MYCOSES .2.

1974 NEW ENGLAND JOURNAL OF MEDICINE 290(18):1022-1023 SPITLER LE PROBLEMS WITH TRANSFER-FACTOR

1974 NOUVELLE PRESSE MEDICALE 3(11):655-660 BACH JF; JUDET C; ARCE S; DORMONT J EXPLORATION OF THYMIC FUNCTION IN MAN .2. SHEEP RED-CELL ROSETTE PHENOMENON, A T-CELL MARKER IN MAN

1974 ONCOLOGY 29(1):46-73 KIRKPATR.CH; GALLIN JI TREATMENT OF INFECTIOUS AND NEOPLASTIC DISEASES WITH TRANSFER- FACTOR

1974 ONCOLOGY 29(6):449-& DECARVALHO S CYTOLOGIC EXPRESSIONS OF SPONTANEOUS TUMOR-SPECIFIC IMMUNITY IN AN UNTREATED MYELOMONOCYTIC LEUKEMIA - SUSTAINED, COMPLETE REMISSION FOLLOWING MINIMAL IMMUNOSUPPRESSIVE THERAPY

1974 PEDIATRIC CLINICS OF NORTH AMERICA 21(3):533-549 ROSEN FS PRIMARY IMMUNODEFICIENCY

1974 PEDIATRIC CLINICS OF NORTH AMERICA 21(4):745-776 GELFAND EW; BIGGAR WD; ORANGE RP IMMUNE DEFICIENCY - EVALUATION, DIAGNOSIS, AND THERAPY

1974 PEDIATRICS 53(1):55-70 SHURTLEF.DB; FOLTZ EL; WEEKS RD; LOESER J THERAPY OF STAPHYLOCOCCUS EPIDERMIDIS - INFECTIONS ASSOCIATED WITH CEREBROSPINAL-FLUID SHUNTS

1974 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 71(2):498-502 GALLIN JI; KIRKPATR.CH CHEMOTACTIC ACTIVITY IN DIALYZABLE TRANSFER-FACTOR

1974 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 71(3):867-871 DUPONT B; BALLOW M; HANSEN JA; QUICK C; YUNIS EJ; GOOD RA EFFECT OF TRANSFER-FACTOR THERAPY ON MIXED LYMPHOCYTE CULTURE REACTIVITY

1974 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 71(4):1178-1182 ASCHER MS; SCHNEIDE.WJ; VALENTIN.FT; LAWRENCE HS INVITRO PROPERTIES OF LEUKOCYTE DIALYSATES CONTAINING TRANSFER- FACTOR

1974 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 71(6):2319-2323 OETTGEN HF; OLD LJ; FARROW JH; VALENTIN.FT; LAWRENCE HS; THOMAS L EFFECTS OF DIALYZABLE TRANSFER-FACTOR IN PATIENTS WITH BREAST- CANCER

1974 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 71(6):2473-2477 ROSENFEL.S; DRESSLER D TRANSFER-FACTOR - SUBCELLULAR COMPONENT THAT TRANSMITS INFORMATION FOR SPECIFIC IMMUNE-RESPONSES

1974 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 71(11):4429-4434 DRESSLER D; ROSENFEL.S CHEMICAL NATURE OF TRANSFER FACTOR

1974 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 104(4):146-147 FRANCKE C; GROB PJ TRANSFER-FACTOR THERAPY

1974 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 104(43):1501-1506 ROSENTHA.M TRANSFER-FACTOR AND ITS THERAPEUTIC USE

1974 SEMAINE DES HOPITAUX 50(21):417-424 SIMAR J; FOURNIER JL; CAFFIER J; FARRIAUX JP; FONTAINE G WISKOTT-ALDRICH SYNDROME - REPORT OF ONE CASE

1974 SEMINARS IN HEMATOLOGY 11(2):141-202 LEVINE AS; SCHIMPFF SC; GRAW RG; YOUNG RC HEMATOLOGIC MALIGNANCIES AND OTHER MARROW FAILURE STATES - PROGRESS IN MANAGEMENT OF COMPLICATING INFECTIONS

1974 SOUTHERN MEDICAL JOURNAL 67(7):837-840 MUTZ I; LANKFORD J; HUMPHREY GB BIOLOGIC AND CLINICAL IMPLICATIONS OF TRANSFER-FACTOR

1974 TRANSPLANTATION REVIEWS 19():226-254 NELSON DS IMMUNITY TO INFECTION, ALLOGRAFT IMMUNITY AND TUMOR IMMUNITY - PARALLELS AND CONTRASTS

1974 WESTERN JOURNAL OF MEDICINE 120(4):322-325 CLONINGE.P; THRUPP LD; GRANGER GA; NOVEY HS IMMUNOTHERAPY WITH TRANSFER-FACTOR IN DISSEMINATED COCCIDIOIDAL OSTEOMYELITIS AND ARTHRITIS

1975 THE LANCET I: 702 STRANNEGÄRD IL TRANSFER FACTOR IN SEVERE ATOPIC DISEASE

1975 THE LANCET II: 1101 THORNES RD ET AL TRANSFER FACTOR IN HODGKIN’S DISEASE

1975 TRANSPLAN P VII (SUPPL 1) 329-333 VIZA D; GOUST J M; MOULIAS R; TREJDOSIEWICZ L K; COLLARD A; MÜLLER-BÉRAT N ‘IN VITRO’ PRODUCTION OF TRANSFER FACTOR BY LYMPHOBLASTOID CELL LINES

1975 NATURE 258: 14-6 ZUCKERMAN AJ TRANSFER FACTOR IN VIRAL INFECTIONS

1975 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION C- IMMUNOLOGY ():1-54 HALLBERG T HUMAN LYMPHOCYTE SUBPOPULATIONS - STUDIED BY SURFACE MARKERS AND CYTOTOXIC ACTIVITIES INVITRO

1975 AMERICAN JOURNAL OF DISEASES OF CHILDREN 129(5):622-627 SELLARS WA; SOUTH MA WISKOTT-ALDRICH SYNDROME WITH 18-YEAR SURVIVAL - TREATMENT WITH TRANSFER-FACTOR

1975 AMERICAN JOURNAL OF MEDICINE 58(1):129-134 LEVIN DM; LIPSKY PE; KIRKPATRICK CH SELECTIVE HYPOGAMMAGLOBULINEMIA WITH PERSISTENCE OF IGE, MALABSORPTION AND A NUTRITIONALLY DEPENDENT, REVERSIBLE DEFECT IN CELL-MEDIATED-IMMUNITY

1975 ANNALES DE MEDECINE INTERNE 126(10):615-625 GERBEAUX J; BACULARD A; TOURNIER G; MOULIAS R; GOUST JM; DROUHET E; SAINTMARTIN J PARTIAL DEFICIT IN CELLULAR IMMUNITY IN A CHILD SUFFERING FROM CHRONIC CUTANEO-MUCOUS CANDIDIASIS - PULMONARY CRYPTOCOCCOSIS AND INTERCURRENT MENINGITIS

1975 ANNALS OF INTERNAL MEDICINE 83(4):534-552 LUTZNER M; EDELSON R; SCHEIN P; GREEN I; KIRKPATRICK C; AHMED A CUTANEOUS T-CELL LYMPHOMAS - SEZARY SYNDROME, MYCOSIS- FUNGOIDES, AND RELATED DISORDERS

1975 ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY 84(5):607-613 QUICK CA; BEHRENS HW; BRINTONDARNELL M; GOOD RA TREATMENT OF PAPILLOMATOSIS OF LARYNX WITH TRANSFER-FACTOR

1975 ANNALS OF SURGERY 182(1):86-91 HARRIS MN; ROSES DF; CULLIFORD AT; GUMPORT SL MELANOMA OF HEAD AND NECK

1975 ANNALS OF SURGERY 182(3):207-217 MACLEAN LD; MEAKINS JL; TAGUCHI K; DUIGNAN JP; DHILLON KS; GORDON J HOST RESISTANCE IN SEPSIS AND TRAUMA

1975 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 249(FEB28):300-309 WYBRAN J; LEVIN AS; FUDENBERG HH; GOLDSTEIN AL THYMOSIN - EFFECTS ON NORMAL HUMAN-BLOOD T-CELLS

1975 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 249(FEB28):462-467 ELIAS EG; COHEN RM TRANSFER OF DELAYED-HYPERSENSITIVITY BY THYMIC EXTRACT

1975 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 254():592-599 CORMANE RH; HAMERLINCK F; HUSZ S B-LYMPHOCYTES AND T-LYMPHOCYTES IN CERTAIN VARIETIES OF DERMATITIS

1975 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 255(AUG8):597-610 ROBINS RK NUCLEOSIDES AND NUCLEOTIDES - PAST, PRESENT, AND FUTURE

1975 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 15():157-175 JORDAN GW; MERIGAN TC ENHANCEMENT OF HOST DEFENSE-MECHANISMS BY PHARMACOLOGICAL AGENTS

1975 ARCHIVES OF DERMATOLOGY 111(6):711-716 BELCHER RW; PALAZIJ R; WOLINSKY E IMMUNOLOGICAL STUDIES IN PATIENTS WITH SARCOIDOSIS AND CRYPTOCOCCOSIS

1975 ARCHIVES OF OPHTHALMOLOGY 93(8):675-691 OCONNOR GR UVEA

1975 ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY 101(11):664-666 NEIDHART JA; LOBUGLIO AF TRANSFER-FACTOR - POTENTIAL FOR THERAPY OF MALIGNANT DISEASES

1975 ARCHIVES OF SURGERY 110(2):218-220 FARACI RP; HOFFSTRAND HJ; WITEBSKY FG; BLAESE RM; BEAZLEY RM MALIGNANT LYMPHOMA OF JEJUNUM IN A PATIENT WITH WISKOTT-ALDRICH SYNDROME - SURGICAL TREATMENT

1975 AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 5(4):318-323 JOSE DG TREATMENT OF CHRONIC MUCO-CUTANEOUS CANDIDIASIS BY LYMPHOCYTE TRANSFER-FACTOR

1975 BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE 54(6):502-506 SCALISE G TRANSFER-FACTOR THERAPY IN INFECTIOUS-DISEASES

1975 BRITISH JOURNAL OF DERMATOLOGY 92(5):535-540 PARK JR; DEBATS A; RHODES EL EFFECT OF TRANSFER-FACTOR ON INVITRO MIGRATION OF TUBERCULIN STIMULATED WHITE CELLS FROM SARCOID AND NORMAL SUBJECTS

397 1975 CANADIAN JOURNAL OF MEDICAL TECHNOLOGY 37(6):186-189 JONES CR TECHNIQUE FOR DEMONSTRATING THYMUS DERIVED LYMPHOCYTES

1975 CANADIAN JOURNAL OF SURGERY 18(3):259-268 MEAKINS JL HOST DEFENCE MECHANISMS - EVALUATION AND ROLES OF ACQUIRED DEFECTS AND IMMUNOTHERAPY

1975 CANCER 35(3):687-694 DELLON AL; POTVIN C; CHRETIEN PB THYMUS-DEPENDENT LYMPHOCYTE LEVELS IN BRONCHOGENIC CARCINOMA - CORRELATIONS WITH HISTOLOGY, CLINICAL STAGE, AND CLINICAL COURSE AFTER SURGICAL TREATMENT

1975 CANCER 35(3):1007-1014 VIETTI TJ; RAGAB AH COMPLICATIONS AND TOTAL CARE OF A CHILD WITH ACUTE-LEUKEMIA

1975 CANCER 36(1):86-89 KHAN A; HILL JM; MACLELLAN A; LOEB E; HILL NO; THAXTON S IMPROVEMENT IN DELAYED-HYPERSENSITIVITY IN HODGKINS-DISEASE WITH TRANSFER-FACTOR - LYMPHAPHERESIS AND CELLULAR IMMUNE- REACTIONS OF NORMAL DONORS

1975 CANCER 36(6):2179-2191 SCRANTON PE; DECICCO FA; TOTTEN RS; YUNIS EJ PROGNOSTIC FACTORS IN OSTEOSARCOMA - REVIEW OF 20 YEARS EXPERIENCE AT UNIVERSITY-OF-PITTSBURGH HEALTH-CENTER HOSPITALS

1975 CANCER CHEMOTHERAPY REPORTS PART 1 59(5):901-913 BLUMING AZ CURRENT STATUS OF CLINICAL IMMUNOTHERAPY

1975 CELLULAR IMMUNOLOGY 15(2):360-371 CATANZARO A; SPITLER LE; MOSER KM CELLULAR IMMUNE-RESPONSE IN COCCIDIOIDOMYCOSIS

1975 CELLULAR IMMUNOLOGY 15(2):372-381 WALKER AM; GARCIA R; PATE P; MATA LJ; DAVID JR TRANSFER-FACTOR IN IMMUNE DEFICIENCY OF PROTEIN-CALORIE MALNUTRITION - CONTROLLED-STUDY WITH 32 CASES

1975 CELLULAR IMMUNOLOGY 15(2):470-474 KIRKPATRICK CH; GALLIN JI SUPPRESSION OF CELLULAR IMMUNE-RESPONSES FOLLOWING TRANSFER- FACTOR - REPORT OF A CASE

1975 CELLULAR IMMUNOLOGY 15(2):475-478 ZANELLI JM; ADLER WH TRANSFER-FACTOR - TRANSFER OF TUBERCULIN CUTANEOUS SENSITIVITY IN AN ALLOGENEIC AND XENOGENEIC MONKEY MODEL

1975 CELLULAR IMMUNOLOGY 17(2):560-566 MENDES NF; SARAIVA PJ; SANTOS OBO RESTORATIVE EFFECT OF NORMAL HUMAN-SERUM, TRANSFER-FACTOR, AND THYMOSIN ON ABILITY OF HEATED HUMAN LYMPHOCYTES TO FORM ROSETTES WITH SHEEP ERYTHROCYTES

1975 CELLULAR IMMUNOLOGY 19(1):8-21 RYTEL MW; AABERG TM; DEE TH; HEIM LH THERAPY OF CYTOMEGALOVIRUS RETINITIS WITH TRANSFER-FACTOR

1975 CELLULAR IMMUNOLOGY 19(2):201-218 SPITLER LE; LEVIN AS; STITES DP; FUDENBERG HH; HUBER H WISKOTT-ALDRICH SYNDROME - IMMUNOLOGICAL STUDIES IN 9 PATIENTS AND SELECTED FAMILY MEMBERS

1975 CELLULAR IMMUNOLOGY 19(2):219-229 BALLOW M; GOOD RA REPORT OF A PATIENT WITH T-CELL DEFICIENCY AND NORMAL B-CELL FUNCTION - NEW IMMUNODEFICIENCY DISEASE WITH RESPONSE TO TRANSFER-FACTOR

1975 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 19(1):1-9 RACHELEFSKY GS; MCCONNACHIE PR; AMMANN AJ; TERASAKI PI; STIEHM ER ANTIBODY-DEPENDENT LYMPHOCYTE KILLER FUNCTION IN HUMAN IMMUNODEFICIENCY DISEASES

1975 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 19(1):17-32 KANRA GY; VESIKARI T CYTOTOXIC ACTIVITY AGAINST RUBELLA-INFECTED CELLS IN SUPERNATANTS OF HUMAN LYMPHOCYTE-CULTURES STIMULATED BY RUBELLA-VIRUS

1975 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 20(1):1-16 OON CJ; HOBBS JR CLINICAL APPLICATIONS OF CONTINUOUS-FLOW BLOOD SEPARATOR MACHINE

1975 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 20(3):397-408 KAFFE S; PETIGROW CS; CAHILL LT; PERLMAN D; MOLOSHOK RE; HIRSCHHORN K; PAPAGEORGIOU PS VARIABLE CELL-MEDIATED IMMUNE DEFECTS IN A FAMILY WITH CANDIDA ENDOCRINOPATHY SYNDROME

1975 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 21(3):520-524 STEVENS DA; FERRINGTON RA; MERIGAN TC; MARINKOVICH VA RANDOMIZED TRIAL OF TRANSFER-FACTOR TREATMENT OF HUMAN WARTS

1975 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 3(4):476-481 POTVIN C; TARPLEY JL; CHRETIEN B THYMUS-DERIVED LYMPHOCYTES IN PATIENTS WITH SOLID MALIGNANCIES

1975 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 4(3):405-414 HOROWITZ S; GROSHONG T; ALBRECHT R; HONG R ACTIVE ROSETTE TEST IN IMMUNODEFICIENCY DISEASES

1975 CLINICS IN HAEMATOLOGY 4(3):567-607 GALLIN JI; WOLFF SM LEUKOCYTE CHEMOTAXIS - PHYSIOLOGICAL CONSIDERATIONS AND ABNORMALITIES

1975 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D 280(3):371-374 GOUST JM; VIZA D; MOULIAS R; TREJDOSIEWICZ L; LESOURD B; MARESCOT MR DIALYZABLE TRANSFER-FACTOR - INVITRO PRODUCTION BY LYMPHOBLASTOID CELL LINES

1975 DANISH MEDICAL BULLETIN 22(5):181-194 CLAUSEN JE AGAROSE MIGRATION-INHIBITION TECHNIQUE FOR INVITRO DEMONSTRATION OF CELL-MEDIATED-IMMUNITY IN MAN - REVIEW

1975 EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 5(1):33-43 GROB PJ; FRANKE C; REYMOND JF; FREIWETTSTEIN M THERAPEUTIC USE OF TRANSFER-FACTOR

1975 HAUTARZT 26(5):260-263 OTTOLENGHI F; ANDREASSI L; SBANO E; FIMIANI M CHRONIC MUCOCUTANEOUS CANDIDOSIS - EFFECTS OF ANTIMYCOTICS INVITRO

1975 IMMUNOCHEMISTRY 12(6-7):485-489 WELIKY N REFLECTIONS ON SOME ASPECTS OF CHEMISTRY IN IMMUNOCHEMISTRY - MOLECULAR DISCRIMINATION AND DETERMINATION

1975 IMMUNOLOGY 28(1):127-132 HAN T; PAULY JL; MITTELMAN A ADOPTIVE TRANSFER OF CELL-MEDIATED-IMMUNITY TO TUBERCULIN USING RNA FROM TUBERCULIN-SENSITIVE SUBJECTS

1975 INTERNIST 16(10):486-491 GROB PJ IMMUNOSTIMULATION FOR SEVERE INFECTIONS

1975 JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY 28(1):11-22 KOBAYAKAWA T CELL-MEDIATED-IMMUNITY TO DIROFILARIA-IMMITIS

1975 JOHNS HOPKINS MEDICAL JOURNAL 136(6):243-250 ZIZIC TM; STEVENS MB ARTHROPATHY OF BEHCETS DISEASE

1975 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 55(6):411-421 KIRKPATRICK CH PROPERTIES AND ACTIVITIES OF TRANSFER-FACTOR

1975 JOURNAL OF CLINICAL INVESTIGATION 55(3):487-499 LEVIN AS; BYERS VS; FUDENBERG HH; WYBRAN J; HACKETT AJ; JOHNSTON JO; SPITLER LE OSTEOGENIC SARCOMA - IMMUNOLOGICAL PARAMETERS BEFORE AND DURING IMMUNOTHERAPY WITH TUMOR-SPECIFIC TRANSFER-FACTOR

1975 JOURNAL OF CLINICAL INVESTIGATION 55(5):967-974 GALLIN JI; DUROCHER JR; KAPLAN AP INTERACTION OF LEUKOCYTE CHEMOTACTIC FACTORS WITH CELL-SURFACE .1. CHEMOTACTIC FACTOR-INDUCED CHANGES IN HUMAN GRANULOCYTE SURFACE CHARGE

1975 JOURNAL OF CLINICAL INVESTIGATION 56(5):1271-1279 SANDLER JA; SMITH TK; MANGANIELLO VC; KIRKPATRICK CH STIMULATION OF MONOCYTE CGMP BY LEUKOCYTE DIALYSATES - ANTIGEN- INDEPENDENT PROPERTY OF DIALYZABLE TRANSFER-FACTOR

1975 JOURNAL OF CLINICAL MICROBIOLOGY 1(3):279-288 SAHA K; MITTAL MM; MAHESHWARI HB PASSIVE TRANSFER OF IMMUNITY INTO LEPROSY PATIENTS BY TRANSFUSION OF LYMPHOCYTES AND BY TRANSFUSION OF LAWRENCES TRANSFER-FACTOR

1975 JOURNAL OF IMMUNOLOGICAL METHODS 8(3):241-249 SCHAFER LA; GUTTERMAN JU; MAVLIGIT GM; REED RC; HERSH EM PERMANENT SLIDE PREPARATIONS OF T-LYMPHOCYTE SHEEP RED BLOOD- CELL ROSETTES

1975 JOURNAL OF IMMUNOLOGY 114(1):274-278 POSTLETHWAITE AE; SNYDERMAN R CHARACTERIZATION OF CHEMOTACTIC ACTIVITY PRODUCED INVIVO BY A CELL-MEDIATED IMMUNE-REACTION IN GUINEA-PIG

1975 JOURNAL OF IMMUNOLOGY 115(4):1018-1022 NAMBA Y; WAKSMAN BH REGULATORY SUBSTANCES PRODUCED BY LYMPHOCYTES .2. LYMPHOTOXIN IN RAT

1975 JOURNAL OF INFECTIOUS DISEASES 132(3):250-255 OPELZ G; SCHEER MI CUTANEOUS SENSITIVITY AND INVITRO RESPONSIVENESS OF LYMPHOCYTES IN PATIENTS WITH DISSEMINATED COCCIDIOIDOMYCOSIS

1975 JOURNAL OF NEUROLOGY 211(1):39-49 KACKELL YM; GROB PJ; KRETH WH; KIBLER R; MEULEN VT TRANSFER-FACTOR THERAPY IN PATIENTS WITH SUBACUTE SCLEROSING PANENCEPHALITIS

1975 JOURNAL OF PEDIATRICS 87(6):1094-1102 FLORMAN AL; HOLZMAN RS NONSPECIFIC ENHANCERS OF RESISTANCE IN MAN

1975 JOURNAL OF THE NATIONAL CANCER INSTITUTE 55(5):1135-1142 HOLT PG; CHALMER J; KEAST D DEVELOPMENT OF 2 MANIFESTATIONS OF T-LYMPHOCYTE REACTIVITY DURING TUMOR-GROWTH - ALTERED KINETICS ASSOCIATED WITH ELEVATED GROWTH-RATES

1975 LANCET 2(7941):901-903 NG RP; ALEXOPOULOS CG; MORAN CJ; BELLINGHAM AJ TRANSFER-FACTOR IN HODGKINS-DISEASE

1975 MILITARY MEDICINE 140(12):846-852 CALDWELL CW; BURNINGHAM RA LYMPHOCYTE PHYSIOLOGY AND FUNCTION

1975 NEW ENGLAND JOURNAL OF MEDICINE 292(9):439-443 GROSS RL; LATTY A; WILLIAMS EA; NEWBERNE PM ABNORMAL SPONTANEOUS ROSETTE FORMATION AND ROSETTE INHIBITION IN LUNG CARCINOMA

1975 NEW ENGLAND JOURNAL OF MEDICINE 292(9):475-476 FUDENBERG HH; WYBRAN J; ROBBINS D T-ROSETTE-FORMING CELLS, CELLULAR IMMUNITY AND CANCER

1975 NEW ENGLAND JOURNAL OF MEDICINE 292(16):869-869 WARA DW; AMMANN AJ; GOLDSTEIN AL TRANSFER-FACTOR THYMOSIN AND E ROSETTES - REPLY

1975 ONCOLOGY 32(5-6):269-274 SHIFRINE M; SCIBIENSKI R TRANSFER-FACTOR - HYPOTHESES FOR ITS STRUCTURE AND FUNCTION

1975 PEDIATRICS 55(2):157-160 SEEGER RC; STIEHM ER T-LYMPHOCYTE AND B-LYMPHOCYTE SUBPOPULATIONS

1975 PRACTITIONER 214(1282):511-521 OLIVER RTD IMMUNOLOGICAL ASPECTS OF MALIGNANT DISEASE

1975 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 72(11):4573-4576 DUNNICK W; BACH FH GUINEA-PIG TRANSFER FACTOR-LIKE ACTIVITY DETECTED INVITRO

1975 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 149(1):199-202 BANG BG; MAHALANABIS D; MUKHERJEE KL; BANG FB T-LYMPHOCYTE AND B-LYMPHOCYTE ROSETTING IN UNDERNOURISHED CHILDREN

1975 REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE 15(4):229-237 SERROU B THEORETICAL BASIS AND RESULTS OF IMMUNOLOGICAL DETERMINATIONS IN CANCEROLOGY

1975 SABOURAUDIA-JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY 13(JUL):123-131 JENSSEN HL; KOHLER H; KABEN U; WESTPHAL HJ CELL ELECTROPHORETIC STUDIES OF CELLULAR IMMUNE-RESPONSE TO CANDIDA-ALBICANS IN RABBITS

1975 SCANDINAVIAN JOURNAL OF RESPIRATORY DISEASES 56(1):1-19 HEDFORS E IMMUNOLOGICAL ASPECTS OF SARCOIDOSIS

1975 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 105(52):1805-1814 ZORTEACAFLISCH C; ODERMATT B; RUTTNER JR; GROB PJ DIAGNOSTIC IMPORTANCE OF IMMUNOLOGICAL DIFFERENTIATION OF CIRCULATING LYMPHOCYTES

1975 SEMINARS IN ROENTGENOLOGY 10(1):7-19 ROBERTS SR IMMUNOLOGY AND LUNG - OVERVIEW

1975 SOUTHERN MEDICAL JOURNAL 68(4):495-503 KOPF AW IMMUNOTHERAPY FOR HUMAN MALIGNANT-MELANOMA

1975 SOUTHERN MEDICAL JOURNAL 68(5):615-622 PARK BH IMMUNOLOGICAL RECONSTITUTION IN MAN - PRESENT STATUS

1975 SOUTHERN MEDICAL JOURNAL 68(12):1545-1551 MADDISON SE DIALYZABLE TRANSFER-FACTOR

1975 SURGERY GYNECOLOGY & OBSTETRICS 141(5):779-794 BURDICK JF; WELLS SA; HERBERMAN RB IMMUNOLOGICAL EVALUATION OF PATIENTS WITH CANCER BY DELAYED- HYPERSENSITIVITY REACTIONS

1975 TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 69(5-6):488-493 WARREN KS; COOK JA; DAVID JR; JORDAN P PASSIVE TRANSFER OF IMMUNITY IN HUMAN SCHISTOSOMIASIS MANSONI - EFFECT OF TRANSFER-FACTOR ON EARLY ESTABLISHED INFECTIONS

1975 TRANSPLANTATION PROCEEDINGS 7(2):281-285 RAPAPORT FT; LAWRENCE HS POSSIBLE ROLE FOR CROSS-REACTING ANTIGENS IN CONDITIONING IMMUNOLOGICAL SURVEILLANCE MECHANISMS IN CANCER AND TRANSPLANTATION .2. PROSPECTIVE STUDIES OF ALTERED CELLULAR IMMUNE REACTIVITY IN CANCER-PATIENTS

1975 TRANSPLANTATION PROCEEDINGS 7(3):449-452 KLESIUS PH; KRAMER T; BURGER D; MALLEY A PASSIVE TRANSFER OF COCCIDIAN OOCYST ANTIGEN AND DIPHTHERIA TOXOID HYPERSENSITIVITY IN CALVES ACROSS SPECIES BARRIERS

1975 VOX SANGUINIS 28(4):257-277 BASTEN A; CROFT S; KENNY DF; NELSON DS USES OF TRANSFER-FACTOR

1975 VOX SANGUINIS 29(5):338-351 REYMOND JF; GROB PJ TRANSFER-FACTOR PREPARATIONS - SOME PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES

1975 VOX SANGUINIS 29(5):352-362 WIT JJFMD; HENRICHS HJP; ODINK J; PRINS HK EXPERIMENTS ON PREPARATION OF BLOOD COMPONENTS WITH IBM 2991 BLOOD-CELL PROCESSOR

1975 YALE JOURNAL OF BIOLOGY AND MEDICINE 48(5):423-429 ARIYAN S PROGRESS OF IMMUNOTHERAPY IN TREATMENT OF MALIGNANT-MELANOMA

1975 ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII (12):114-119 NOVIKOV DK; GORBACH IN; GORBACH AD TRANSFER TO LEUKOCYTES OF NEONATES BY PLASMA OF PATIENTS WITH TUBERCULOSIS AND HEALTHY PERSONS OF CAPACITY TO DEPRESS MIGRATION UNDER EFFECT OF ANTIGENS OF MYCOBACTERIA TUBERCULOSIS INVITRO

1976 BR J CANC 33: 606-611 PIZZA G ; VIZA D ; BOUCHEIX C ; CORRADO F IN VITRO PRODUCTION OF A TRANSFER FACTOR SPECIFIC FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER

1976 ANN OPHTHALMOL 427-32 SMOLIN G AND OKUMOTO M HUMAN TRANSFER FACTOR IN THE TREATMENT OF GUINEA PIG KERATITIS

1976 ACTA DERMATO-VENEREOLOGICA 56(1):47-49 SZEGEDI G; NAGY E; TAMASI P; GERGELY P; SONKOLY I STUDIES ON T AND B LYMPHOCYTES IN PERIPHERAL-BLOOD OF DISCOID LUPUS-ERYTHEMATOSUS PATIENTS WITH AND WITHOUT CHLOROQUINE TREATMENT

1976 ACTA PAEDIATRICA ACADEMIAE SCIENTIARUM HUNGARICAE 17(3):183-191 KARMAZSIN L; OLAH E; SZEGEDI G TRANSFER-FACTOR TREATMENT OF CHRONIC MUCOCUTANEOUS CANDIDIASIS

1976 AMERICAN JOURNAL OF DISEASES OF CHILDREN 130(4):433-436 PASSWELL J; KATZ D; FRANK Y; SPIRER Z; COHEN BE; ZIPRKOWSKI M FATAL DISSEMINATED BCG INFECTION - INVESTIGATION OF IMMUNODEFICIENCY

1976 AMERICAN JOURNAL OF MEDICINE 61(2):283-286 STEELE RW; SIEGER BE; MCNITT TR; GENTRY LO; MOORE WL THERAPY FOR DISSEMINATED COCCIDIOIDOMYCOSIS WITH TRANSFER- FACTOR FROM A RELATED DONOR

1976 ANNALS OF ALLERGY 36(5):330-336 KHAN A; THOMETZ D; GARRISON O; HILL JM INCREASE IN E-ROSETTES AFTER TRANSFER-FACTOR (TF) TREATMENT - FRACTIONATION OF TF

1976 ANNALS OF ALLERGY 37(4):267-274 KHAN A; SELLARS WA; PFLANZER J; HILL JM; THOMETZ D; HAENKE J ASTHMA AND T-CELL IMMUNODEFICIENCY - IMPROVEMENT WITH TRANSFER FACTOR AND IMMUNOPEPTIDE-1

1976 ANNALS OF ALLERGY 37(6):383-390 HSIEH KH STUDY OF E-ROSETTES, SERUM IGE AND EOSINOPHILIA IN ASTHMATIC- CHILDREN

1976 ANNALS OF INTERNAL MEDICINE 84(2):193-199 RUSKIN J; REMINGTON JS TOXOPLASMOSIS IN COMPROMISED HOST

1976 ANNALS OF INTERNAL MEDICINE 84(4):505-509 [ANON] ALLERGY AND CLINICAL IMMUNOLOGY - ANNOTATED-BIBLIOGRAPHY OF RECENT LITERATURE - REFERENCES TO JOURNAL ARTICLES AND OTHER PAPERS

1976 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 277(SEP20):516-521 JEWELL WR; THOMAS JH; MORSE P; HUMPHREY LJ COMPARISON OF ALLOGENEIC TUMOR VACCINE WITH LEUKOCYTE TRANSFER AND TRANSFER-FACTOR TREATMENT OF HUMAN CANCER

1976 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 277(SEP20):545-557 FUDENBERG HH DIALYZABLE TRANSFER-FACTOR IN TREATMENT OF HUMAN OSTEOSARCOMA - ANALYTIC REVIEW 479

1976 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 278(SEP9):129-135 HORSMANHEIMO M; VIROLAINEN M ACQUISITION OF TUBERCULIN SENSITIVITY AFTER INJECTION OF DIALYZABLE TRANSFER-FACTOR IN SARCOIDOSIS

1976 ARCHIVES OF DERMATOLOGY 112(5):706-708 HIRSH FS; SAFFOLD OE MYCOBACTERIUM-KANSASII INFECTION WITH DERMATOLOGIC MANIFESTATIONS

1976 ARCHIVES OF DERMATOLOGY 112(6):791-800 REA TH; QUISMORIO FP; HARDING B; NIES KM; DISAIA PJ; LEVAN NE; FRIOU GJ IMMUNOLOGICAL RESPONSES IN PATIENTS WITH LEPROMATOUS LEPROSY

1976 ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 100(5):283-286 WISE WS; STILL WJS; JOSHI VV SEVERE COMBINED IMMUNODEFICIENCY WITH THYMIC MAST-CELL HYPERPLASIA

1976 ARTHRITIS AND RHEUMATISM 19(6):973-& [ANON] 22ND RHEUMATISM REVIEW - REVIEW OF AMERICAN AND ENGLISH LITERATURE FOR YEARS 1973 AND 1974

1976 BACTERIOLOGICAL REVIEWS 40(2):284-313 CAMPBELL PA IMMUNOCOMPETENT CELLS IN RESISTANCE TO BACTERIAL-INFECTIONS

1976 BIOMEDICINE 24(1):39-44 GOUST JM; MARESCOT MR; LESOURD B; DOUMERCQ S; MOULIAS R CHARACTERIZATION OF HUMAN DIALYZABLE TRANSFER-FACTOR FROM NORMAL AND CHRONIC LYMPHOID LEUKEMIA SOURCES

1976 BIOMEDICINE EXPRESS 25(6):218-220 LEBRUN F; SABOLOVIC D; LEBOVICI S; AMIEL C; AMIEL JL ELECTROPHORETIC MOBILITY OF LYMPHOCYTES IN NEW BORN

1976 BLUT 32(5):353-360 MUELLERECKHARDT C; RITTS RE INHIBITORY ACTIVITY OF MEDIUM-DIALYZED TRANSFER-FACTOR ON LYMPHOCYTE BLASTOGENESIS

1976 BLUT 33(4):253-264 GENTH E; HARTL W; HANNIG H; STEFFENS E LYMPHOCYTOPENIA IN PSEUDO-LUPUS ERYTHEMATOSUS SYNDROME

1976 BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE 55(2):168-173 PASINO M; VADALA CR; TONINI GP; COMELLI A; PERUTELLI P ASPECIFIC TRANSFER-FACTOR IN CHILDREN WITH HODGKINS-DISEASE

1976 BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE 55(5):396-399 BARICORDI OR ENRICHMENT OF B LYMPHOCYTES FROM HUMAN PERIPHERAL-BLOOD BY SEDIMENTATION OF E ROSETTE STABILIZED WITH DEXTRAN

1976 BRITISH JOURNAL OF ANAESTHESIA 48(9):877-880 SALO M; VAPAAVUORI M PERIPHERAL-BLOOD T-LYMPHOCYTES AND B-LYMPHOCYTES IN OPERATING- THEATER PERSONNEL

1976 BRITISH JOURNAL OF DERMATOLOGY 94(1):79-83 SOUSA MD; COCHRAN R; MACKIE R; PARRATT D; ARALACHAVES M CHRONIC MUCOCUTANEOUS CANDIDIASIS TREATED WITH TRANSFER-FACTOR

1976 BRITISH JOURNAL OF DERMATOLOGY 94(1):107-109 MACKIE RM TRANSFER-FACTOR 1975

1976 CANADIAN JOURNAL OF SURGERY 19(1):12-22 PROCTOR JW; LEWIS MG; MANSELL PW IMMUNOTHERAPY FOR CANCER - OVERVIEW

1976 CANADIAN MEDICAL ASSOCIATION JOURNAL 114(2):140-& SMALL P; LEVITT P DISSEMINATED HISTOPLASMOSIS AND NECROTIZING VASCULITIS

1976 CANCER 37(1):90-97 VETTO RM; BURGER DR; NOLTE JE; VANDENBARK AA; BAKER HW TRANSFER-FACTOR THERAPY IN PATIENTS WITH CANCER

1976 CANCER 37(4):2029-2148 [ANON] RESEARCH PLAN FOR RADIATION ONCOLOGY

1976 CANCER IMMUNOLOGY IMMUNOTHERAPY 1(3):119-126 SIMMLER MC; BRULEYROSSET M IMMUNODEFICIENCY IN CANCER-PATIENTS AND IMMUNORESTORATION

1976 CANCER IMMUNOLOGY IMMUNOTHERAPY 1(3):153-156 WYBRAN J; SPITLER LE; LIEBERMAN R; FUDENBERG HH ACTIVE T-CELLS ROSETTES AND TOTAL T-ROSETTES IN PATIENTS WITH MELANOMA FOLLOWING INTRATUMORAL INOCULATION OF BCG - CLUE TO MECHANISM OF ACTION OF BACILLUS CALMETTE-GUERIN

1976 CANCER RESEARCH 36(2):720-723 GOLDENBERG GJ; BRANDES LJ INVIVO AND INVITRO STUDIES OF IMMUNOTHERAPY OF NASOPHARYNGEAL CARCINOMA WITH TRANSFER-FACTOR

1976 CELLULAR IMMUNOLOGY 21(1):1-19 SPITLER LE; LEVIN AS; WYBRAN J COMBINED IMMUNOTHERAPY IN MALIGNANT-MELANOMA - REGRESSION OF METASTATIC LESIONS IN 2 PATIENTS CONCORDANT IN TIMING WITH SYSTEMIC ADMINISTRATION OF TRANSFER-FACTOR AND BACILLUS CALMETTE-GUERIN

1976 CELLULAR IMMUNOLOGY 21(1):161-176 WAKSMAN BH; NAMBA Y SOLUBLE MEDIATORS OF IMMUNOLOGICAL REGULATION

1976 CELLULAR IMMUNOLOGY 22(1):110-120 STEELE RW; EICHBERG JW; HEBERLING RL; ELLER JJ; KALTER SS; KNIKER WT INVIVO TRANSFER OF CELLULAR IMMUNITY TO PRIMATES WITH TRANSFER- FACTOR PREPARED FROM HUMAN OR PRIMATE LEUKOCYTES

1976 CELLULAR IMMUNOLOGY 23(2):191-202 ODORISIO MS; NEIDHART JA; DANIEL FB; BALCERZAK SP; LOBUGLIO AF IDENTIFICATION OF HYPOXANTHINE AS MAJOR COMPONENT OF A CHROMATOGRAPHIC FRACTION OF TRANSFER-FACTOR

1976 CELLULAR IMMUNOLOGY 24(2):230-240 KIRKPATRICK CH; ROBINSON LB; SMITH TK IDENTIFICATION AND SIGNIFICANCE OF HYPOXANTHINE IN DIALYZABLE TRANSFER-FACTOR

1976 CELLULAR IMMUNOLOGY 26(1):114-119 EICHBERG JW; STEELE RW; KALTER SS; KNIKER WT; HEBERLING RL; ELLER JJ; RODRIGUEZ AR CELLULAR IMMUNITY IN GNOTOBIOTIC PRIMATES INDUCED BY TRANSFER- FACTOR

1976 CELLULAR IMMUNOLOGY 27(2):323-327 KIRKPATRICK CH; SMITH TK SERIAL TRANSFER OF DELAYED-HYPERSENSITIVITY WITH DIALYZABLE TRANSFER-FACTOR

1976 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 23(2):290-302 HAMBLIN AS; MAINI RN; DUMONDE DC HUMAN TRANSFER-FACTOR INVITRO .1. AUGMENTATION OF LYMPHOCYTE- TRANSFORMATION TO TUBERCULIN PPD

1976 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 23(2):303-313 HAMBLIN AS; DUMONDE DC; MAINI RN HUMAN TRANSFER-FACTOR INVITRO .2. AUGMENTATION OF LYMPHOCYTE- TRANSFORMATION TO PHYTOHEMAGGLUTININ

1976 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 23(3):414-428 KIRKPATRICK CH; OTTENSON EA; SMITH TK; WELLS SA; BURDICK JF RECONSTITUTION OF DEFECTIVE CELLULAR IMMUNITY WITH FETAL THYMUS AND DIALYZABLE TRANSFER-FACTOR - LONG-TERM STUDIES IN A PATIENT WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS

1976 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 23(3):499-506 AHERN T; SANDERSON CJ STIMULATION OF LYMPHOCYTES BY ANTIGEN IN MICROPLATE CULTURES - ABSENCE OF AN EFFECT OF TRANSFER-FACTOR INVITRO

1976 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 24(2):370-373 TANIGUCHI N; OKUDA N; MORIYA N; MIYAWAKI T; NAGAOKI T INHIBITORY EFFECT OF SHEEP ERYTHROCYTE FRAGMENTS ON ROSETTE FORMATION OF HUMAN T LYMPHOCYTES WITH SHEEP RED BLOOD-CELLS

1976 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 5(1):142-146 LIEBERMAN R; HSU M LEVAMISOLE-MEDIATED RESTORATION OF CELLULAR IMMUNITY IN PERIPHERAL-BLOOD LYMPHOCYTES OF PATIENTS WITH IMMUNODEFICIENCY DISEASES

1976 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 5(3):407-415 WELCH TM; TRIGLIA R; SPITLER LE; FUDENBERG HH PRELIMINARY STUDIES ON HUMAN TRANSFER-FACTOR ACTIVITY IN GUINEA-PIGS - SYSTEMIC TRANSFER OF CUTANEOUS DELAYED-TYPE HYPERSENSITIVITY TO PPD AND SKSD

1976 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 6(2):231-237 HORSMANHEIMO M; VIROLAINEN M TRANSFER OF TUBERCULIN SENSITIVITY BY TRANSFER-FACTOR IN SARCOIDOSIS

1976 CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (120):95-102 JAFFE N OSTEOGENIC SARCOMA - STATE OF ART WITH HIGH-DOSE METHOTREXATE TREATMENT

1976 EXPERIMENTAL PARASITOLOGY 39(1):29-39 MADDISON SE; HICKLIN MD; KAGAN IG SCHISTOSOMA-MANSONI - REDUCTION IN CLINICAL MANIFESTATIONS AND IN WORM BURDENS CONFERRED BY SERUM AND TRANSFER-FACTOR FROM IMMUNE OR NORMAL RHESUS-MONKEYS

1976 HAUTARZT 27(1):1-7 TRITSCH H TRENDS IN IMMUNOTHERAPY OF MALIGNANT-MELANOMA

1976 IMMUNOLOGICAL COMMUNICATIONS 5(7-8):685-694 KERMAN R; SMITH R; EZDINLI E; STEFANI S UNIFICATION AND TECHNICAL ASPECTS OF TOTAL T, ACTIVE T AND B LYMPHOCYTE ROSETTE ASSAYS1

1976 IMMUNOLOGY 31(5):677-687 RYZEWSKA AG; DABROWSKA BK LYMPHOKINE IN RAT .1. EVIDENCE THAT LYMPHOTOXIN ACTIVITY INVOLVES BOTH CYTOTOXIC AND STIMULATING FACTORS

1976 INFECTION AND IMMUNITY 14(1):290-297 PAQUET A; OLSON GB; JETER WS INVITRO ACTIVITY OF GUINEA-PIG TRANSFER-FACTOR RELEASED INTO PLASMA

1976 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 50(5):593-605 MULLER MR; LAZARY S; HITZIG WH PRODUCTION OF MIGRATION-INHIBITORY FACTOR AND BLAST CELL TRANSFORMATION BY CORD BLOOD-LYMPHOCYTES

1976 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 51(5):560-573 HOLT PG; FIMMEL PJ; BARTHOLOMAEUS WN; ROBERTS LM; TANDON MK; KEAST D DISSOCIATION OF CORRELATES OF CELLULAR IMMUNITY IN MAN - FUNCTIONAL HETEROGENEITY WITHIN ANTIGEN-REACTIVE CELL- POPULATION

1976 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 235(19):2132-2134 CODISH SD; TOBIAS JS MANAGING SYSTEMIC MYCOSES IN COMPROMISED HOST

1976 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 58(1):190-197 TOMAR RH; KNIGHT R; STERN M TRANSFER-FACTOR - HYPOXANTHINE IS A MAJOR COMPONENT OF A FRACTION WITH INVIVO ACTIVITY

1976 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 58(2):337-350 EHTESSABIAN R; CASSIDY JT; THOMAS MR; MATHEWS KP; TUBERGEN DG COMMON VARIABLE IMMUNODEFICIENCY WITH PERNICIOUS-ANEMIA, ASTHMA, AND REACTIONS TO GAMMA-GLOBULIN - TREATMENT WITH PLASMA

1976 JOURNAL OF CLINICAL INVESTIGATION 57(5):1227-1238 CHISARI FV; ROUTENBERG JA; EDGINGTON TS MECHANISMS RESPONSIBLE FOR DEFECTIVE HUMAN T-LYMPHOCYTE SHEEP ERYTHROCYTE ROSETTE FUNCTION ASSOCIATED WITH HEPATITIS B VIRUS- INFECTIONS

1976 JOURNAL OF EXPERIMENTAL MEDICINE 143(4):791-804 COHEN L; HOLZMAN RS; VALENTINE FT; LAWRENCE HS REQUIREMENT OF PRECOMMITTED CELLS AS TARGETS FOR AUGMENTATION OF LYMPHOCYTE-PROLIFERATION BY LEUKOCYTE DIALYSATES

1976 JOURNAL OF IMMUNOLOGY 116(4):1110-1114 FELSBURG PJ; EDELMAN R; GILMAN RH ACTIVE-E ROSETTE TEST - CORRELATION WITH DELAYED CUTANEOUS HYPERSENSITIVITY

1976 JOURNAL OF IMMUNOLOGY 116(4):1140-1144 NAMBA Y; WAKSMAN BH REGULATORY SUBSTANCES PRODUCED BY LYMPHOCYTES .3. EVIDENCE THAT LYMPHOTOXIN AND PROLIFERATION INHIBITORY FACTOR ARE IDENTICAL AND DIFFERENT FROM INHIBITOR OF DNA-SYNTHESIS

1976 JOURNAL OF IMMUNOLOGY 117(1):283-291 LEE SC; LUCAS ZJ REGULATORY FACTORS PRODUCED BY LYMPHOCYTES .1. OCCURRENCE OF MULTIPLE ALPHA-LYMPHOTOXINS ASSOCIATED WITH RIBONUCLEASE- ACTIVITY

1976 JOURNAL OF IMMUNOLOGY 117(2):523-530 SOHNLE PG; FRANK MM; KIRKPATRICK CH MECHANISMS INVOLVED IN ELIMINATION OF ORGANISMS FROM EXPERIMENTAL CUTANEOUS CANDIDA-ALBICANS INFECTIONS IN GUINEA- PIGS

1976 JOURNAL OF IMMUNOLOGY 117(3):782-788 BURGER DR; VANDENBARK AA; FINKE P; NOLTE JE; VETTO RM HUMAN TRANSFER-FACTOR - EFFECTS ON LYMPHOCYTE-TRANSFORMATION

1976 JOURNAL OF IMMUNOLOGY 117(3):789-796 BURGER DR; VANDENBARK AA; DAVES D; ANDERSON WA; VETTO RM; FINKE P HUMAN TRANSFER-FACTOR - FRACTIONATION AND BIOLOGIC ACTIVITY

1976 JOURNAL OF IMMUNOLOGY 117(5):1716-1720 POSTLETHWAITE AE; TOWNES AS; KANG AH CHARACTERIZATION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR ACTIVITY PRODUCED INVIVO BY A CELL-MEDIATED IMMUNE-REACTION IN GUINEA-PIG

1976 JOURNAL OF INFECTIOUS DISEASES 133(5):533-537 RIFKIND D; FREY JA; PETERSEN EA; DINOWITZ M DELAYED-HYPERSENSITIVITY TO FUNGAL ANTIGENS IN MICE .3. CHARACTERIZATION OF ACTIVE COMPONENT IN IMMUNOGENIC RNA EXTRACTS

1976 JOURNAL OF INVESTIGATIVE DERMATOLOGY 67(1):136-148 CHASE MW DEVELOPMENTS IN DELAYED-TYPE HYPERSENSITIVITIES - 1950-1975

1976 JOURNAL OF INVESTIGATIVE DERMATOLOGY 67(3):402-411 ROSEN FS PRIMARY IMMUNODEFICIENCIES - DERMATOLOGIC MANIFESTATIONS

1976 JOURNAL OF INVESTIGATIVE DERMATOLOGY 67(3):425-430 KIRKPATRICK CH; SMITH TK NATURE OF TRANSFER-FACTOR AND ITS CLINICAL EFFICACY IN MANAGEMENT OF CUTANEOUS DISORDERS

1976 JOURNAL OF INVESTIGATIVE DERMATOLOGY 67(3):435-441 SPITLER LE MALIGNANT-MELANOMA

1976 LANCET 1(7954):263-266 JOSE DG; FORD GW; WELCH JS THERAPY WITH PARENTS LYMPHOCYTE TRANSFER-FACTOR IN CHILDREN WITH INFECTION AND MALNUTRITION

1976 LANCET 1(7967):988-990 BEHAN PO; MELVILLE ID; DURWARD WF; MCGEORGE AP; BEHAN WMH TRANSFER-FACTOR THERAPY IN MULTIPLE-SCLEROSIS

1976 MEDICAL BIOLOGY 54(5):334-340 KROHN K; GROHN P; HORSMANHEIMO M; VIROLAINEN M FRACTIONATION STUDIES ON HUMAN LEUKOCYTE DIALYSATES - DEMONSTRATION OF 3 COMPONENTS WITH TRANSFER-FACTOR ACTIVITY

1976 MEDICAL CLINICS OF NORTH AMERICA 60(3):585-590 LOBUGLIO AF; NEIDHART JA TRANSFER-FACTOR - POTENTIAL AGENT FOR CANCER-THERAPY

1976 MYCOPATHOLOGIA 60(1):17-25 ARONSON IK; SOLTANI K CHRONIC MUCOCUTANEOUS CANDIDOSIS - REVIEW

1976 NATURE 259(5540):250-250 SALAMAN MR; VALDIMARSSON H SPECIFICITY OF TRANSFER-FACTOR

1976 NATURE 262(5564):155-156 ARALACHAVES MP; FUDENBERG HH SPECIFICITY OF TRANSFER-FACTOR

1976 NEUROCHIRURGIA 19(1):10-21 BLAYLOCK RL; KEMPE LG REVIEW AND NEW PROPOSALS FOR IMMUNOTHERAPY OF BRAIN TUMORS

1976 NEW YORK STATE JOURNAL OF MEDICINE 76(1):24-31 GUPTA S CELL-SURFACE MARKERS OF HUMAN T-LYMPHOCYTES AND B-LYMPHOCYTES - THEIR PROFILE IN PRIMARY IMMUNODEFICIENCIES

1976 PEDIATRIC RESEARCH 10(5):517-522 GLADE PR; ZALDIVAR NM; MAYER L; CAHILL LT ROLE OF CELLULAR IMMUNITY IN NEOPLASIA

1976 PROGRESS IN ALLERGY 20():65-194 OPPENHEIM JJ; ROSENSTREICH DL SIGNALS REGULATING INVITRO ACTIVATION OF LYMPHOCYTES

1976 PROGRESS IN ALLERGY 21():178-260 DWYER JM IDENTIFYING AND ENUMERATING HUMAN T AND B LYMPHOCYTES - REVIEW OF TECHNIQUES, PROBLEMS, AND PROGRESS IN CLINICAL STUDIES

1976 REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE 16(5):257-263 GRISCELLI C; HERZOG C; DURANDY A; FISCHER A; MOZZICONACCI P IMMUNOLOGICAL STUDY OF CHRONIC CANDIDOSES IN CHILDREN

1976 SCANDINAVIAN JOURNAL OF IMMUNOLOGY ():69-76 JONDAL M SRBC ROSETTE FORMATION AS A HUMAN T-LYMPHOCYTE MARKER

1976 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 5(1-2):141-148 JERSILD C; PLATZ P; THOMSEN M; DUPONT B; SVEJGAARD A; CIONGOLI AK; FOG T; GROB P TRANSFER-FACTOR TREATMENT OF PATIENTS WITH MULTIPLE-SCLEROSIS .1. PRELIMINARY-REPORT OF CHANGES IN IMMUNOLOGICAL PARAMETERS

1976 SOUTH AFRICAN MEDICAL JOURNAL 50(40):1556-1558 SACKS N; POTGIETER HJ; VANRENSBURG AJ USE OF TRANSFER-FACTOR IN TREATMENT OF MULTIPLE-SCLEROSIS - CASE-REPORT

1976 SURGERY GYNECOLOGY & OBSTETRICS 142(5):765-778 GRECO RS APPLICATION OF TRANSFER-FACTOR TO CLINICAL IMMUNOTHERAPY

1976 WIENER KLINISCHE WOCHENSCHRIFT 88(21):707-709 PICHLER WJ; STINGL G; MICKSCHE M; NEUMANN H; KNAPP W T-LYMPHOCYTE SHIFTS IN PATIENTS WITH MELANOMA AND BRONCHOGENIC CARCINOMA

1976 ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII (5):10-16 SAKHAROV PP; KUDRINA GP CURRENT STATE OF PROBLEM OF NATURE AND ACTION MECHANISM OF TRANSFER-FACTOR

1976 ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII (1):12-18 MEDUNITSYN NV MEDIATORS OF CELLULAR IMMUNITY

1977 ACTA ENDOCRINOLOGICA 85(4):753-759 WALL JR; GRAY B; GREENWOOD DM TOTAL AND ACTIVATED PERIPHERAL-BLOOD T-LYMPHOCYTES IN PATIENTS WITH THYROID DISORDERS

1977 ACTA MEDICA ACADEMIAE SCIENTIARUM HUNGARICAE 34(1-2):53-57 KALMAR L; NEKAM K; GERGELY P; KELEMEN G; PETRANYI G EFFECT OF TRANSFER-FACTOR ON HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL CYCLIC NUCLEOTIDES

1977 ACTA NEUROLOGICA SCANDINAVICA 55():217-226 GROB PJ TRANSFER-FACTOR - GENERAL ASPECTS

1977 ACTA NEUROLOGICA SCANDINAVICA 55():227-237 SPITLER LE; DAU PC IMMUNOTHERAPY IN INFECTIOUS-DISEASE, AUTOIMMUNITY AND CANCER

1977 ACTA NEUROLOGICA SCANDINAVICA 55():239-251 ZABRISKIE JB; ESPINOZA LR; PLANK CR; COLLINS RC CELL-MEDIATED IMMUNITY TO VIRAL-ANTIGENS IN MULTIPLE-SCLEROSIS

1977 ADVANCES IN IMMUNOLOGY 25():213-241 CHESS L; SCHLOSSMAN SF HUMAN LYMPHOCYTE SUB-POPULATIONS

1977 ANNALS OF ALLERGY 38(5):320-322 KHAN A NON-SPECIFICITY OF TRANSFER-FACTOR

1977 ANNALS OF ALLERGY 39(4):237-239 BRASHER GW; STARR JC; MCCOMBS WB; BOURLAND PD T-LYMPHOCYTES IN CHILDREN WITH ALLERGIC RESPIRATORY-DISEASE

1977 BLUT 34(6):471-478 RAINER H; MOSER K INVITRO INVESTIGATIONS WITH HUMAN TRANSFER-FACTOR

1977 BULLETIN DE L INSTITUT PASTEUR 75(1):5-84 WERNER GH; MARAL R; FLOCH F; JOUANNE M TOXICOLOGICAL ASPECTS OF IMMUNOPOTENTIATION BY ADJUVANTS AND IMMUNOSTIMULATING SUBSTANCES

1977 CANCER 39(2):737-743 ORDER SE EFFECTS OF THERAPEUTIC IRRADIATION ON LYMPHOCYTES AND IMMUNITY

1977 CANCER IMMUNOLOGY IMMUNOTHERAPY 2(1):11-19 WEISS DW QUESTIONABLE IMMUNOGENICITY OF CERTAIN NEOPLASMS - WHAT THEN PROSPECTS FOR IMMUNOLOGICAL INTERVENTION IN MALIGNANT DISEASE

1977 CANCER IMMUNOLOGY IMMUNOTHERAPY 2(1):27-39 MANKIEWICZ E; KURTI V; MUNRO DD; WILSON JAS; PAPENBURG R IMMUNOLOGICAL RESPONSES IN PATIENTS WITH PULMONARY CARCINOMA RECEIVING IMMUNOTHERAPY

1977 CELLULAR IMMUNOLOGY 28(1):158-166 LITTMAN BH; HIRSCHMAN EM; DAVID JR AUGMENTATION OF H-3 THYMIDINE INCORPORATION BY HUMAN LYMPHOCYTES IN PRESENCE OF ANTIGEN AND FRACTIONS OF DIALYZABLE TRANSFER-FACTOR - NONSPECIFIC PHENOMENON

1977 CELLULAR IMMUNOLOGY 29(2):410-413 BURGER DR; VANDENBARK AA; FINKE P; VETTO RM DENOVO APPEARANCE OF KLH TRANSFER-FACTOR FOLLOWING IMMUNIZATION

1977 CELLULAR IMMUNOLOGY 31(2):311-320 SAITO K; TAMAKI N; FOSTER LA; BRENNESSEL B; GOTTLIEB AA INHIBITION OF DNA-SYNTHESIS IN LYMPHOCYTES BY DIALYZABLE COMPONENTS OF HUMAN LEUKOCYTE EXTRACTS

1977 CELLULAR IMMUNOLOGY 33(2):233-244 COHEN S; DAVID J; FELDMANN M; GLADE PR; MAYER M; OPPENHEIM JJ; PAPERMASTER BW; PICK E; PIERCE CW; ROSENSTREICH DL; WAKSMAN BH CURRENT STATE OF STUDIES OF MEDIATORS OF CELLULAR IMMUNITY - PROGRESS REPORT

1977 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 27(3):416-420 NEKAM K; KALMAR L; GERGELY P; KELEMEN G; FEKETE B; LANG I; LEVAI J; PETRANYI G INVITRO EFFECT OF TRANSFER-FACTOR ON ACTIVE ROSETTES AND LEUKOCYTE MIGRATION OF PATIENTS WITH CANCER

1977 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 29(2):261-265 VALDIMARSSON H; MCGUIRE RL CRUDE TRANSFER-FACTOR PREPARATIONS STIMULATE TRYPSINIZED HUMAN LYMPHOCYTES TO FORM ROSETTES WITH SHEEP RED-CELLS

1977 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 29(3):376-384 BERKEL AI; ERSOY F; EPSTEIN LB; SPITLER LE TRANSFER-FACTOR THERAPY IN ATAXIA-TELANGIECTASIA

1977 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 30(1):10-15 JAIN S; THOMAS HC; SHERLOCK S TRANSFER-FACTOR IN ATTEMPTED TREATMENT OF PATIENTS WITH HBSAG- POSITIVE CHRONIC LIVER-DISEASE

1977 CLINICAL CHEMISTRY 23(6):1108-1108 LAWRENCE HS TRANSFER-FACTOR IN IMMUNODEFICIENCY

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 7(2):157-167 STAPLES PJ; BOUJAK J; DOUGLAS RG; LEDDY JP DISSEMINATED CANDIDIASIS IN A PREVIOUSLY HEALTHY GIRL - IMPLICATION OF A LEUKOCYTE CANDIDACIDAL DEFECT

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 7(2):187-202 WILSON GB; WELCH TM; FUDENBERG HH TX - COMPONENT IN HUMAN DIALYZABLE TRANSFER-FACTOR THAT INDUCES CUTANEOUS DELAYED-HYPERSENSITIVITY IN GUINEA-PIGS

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 7(2):240-252 KLESIUS PH; KRISTENSEN F BOVINE TRANSFER-FACTOR - EFFECT ON BOVINE AND RABBIT COCCIDIOSIS

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 7(3):372-378 OKUDA N; MORIYA N; MIYAWAKI T; NAGAOKI T; KATO E; TANIGUCHI N BLOCKING EFFECT OF HUMAN T LYMPHOCYTE EXTRACTS ON E-ROSETTE INHIBITION BY SHEEP RED-CELL FRAGMENTS

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(1):7-16 VANDENBARK AA; BURGER DR; VETTO RM HUMAN TRANSFER-FACTOR ACTIVITY IN GUINEA-PIG - ABSENCE OF ANTIGEN SPECIFICITY

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(1):39-50 RUBINSTEIN A; MELAMED J; RODESCU D TRANSFER-FACTOR TREATMENT IN A PATIENT WITH PROGRESSIVE TUBERCULOSIS

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(2):238-246 KLESIUS PH; FUDENBERG HH BOVINE TRANSFER-FACTOR - INVIVO TRANSFER OF CELL-MEDIATED- IMMUNITY TO CATTLE WITH ALCOHOL PRECIPITATES

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(3):430-447 ARALACHAVES MP; SILVA A; PORTO MT; PICOTO A; RAMOS MTF; FUDENBERG HH INVITRO AND INVIVO STUDIES OF TARGET-CELL FOR DIALYZABLE LEUKOCYTE EXTRACTS - EVIDENCE FOR RECIPIENT SPECIFICITY

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(3):504-512 BALLOW M; HYMAN LR COMBINATION IMMUNOTHERAPY IN CHRONIC MUCOCUTANEOUS CANDIDIASIS SYNERGISM BETWEEN TRANSFER-FACTOR AND FETAL THYMUS TISSUE

1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(3):551-568 WILSON GB; WELCH TM; KNAPP DR; HORSMANHEIMO A; FUDENBERG HH CHARACTERIZATION OF TX, AN ACTIVE SUBFRACTION OF HUMAN DIALYZABLE TRANSFER-FACTOR .1. IDENTIFICATION OF MAJOR COMPONENT IN TFG, A PRECURSOR OF TX, AS HYPOXANTHINE

1977 CLINICAL OTOLARYNGOLOGY 2(1):65-75 CASTRO JE IMMUNOTHERAPY OF HEAD AND NECK CANCER

1977 CURRENT SCIENCE 46(23):806-807 MANOHAR V; RAO GR; SIRSI M ADOPTIVE TRANSFER OF CELL-MEDIATED-IMMUNITY TO TRICHOPHYTON- MENTAGROPHYTES IN GUINEA-PIGS

1977 DERMATOLOGICA 154(6):342-349 BERNENGO MG; CAPELLA G; MASCOLI I; ZINA G ACTIVE ROSETTE TEST IN CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS

1977 EUROPEAN JOURNAL OF CANCER 13(9):917-923 PIZZA G; VIZA D; BOUCHEIX C; CORRADO F EFFECT OF INVITRO PRODUCED TRANSFER-FACTOR ON IMMUNE-RESPONSE OF CANCER-PATIENTS

1977 INFECTION AND IMMUNITY 16(1):258-262 RIFKIND D; FREY JA; PETERSEN EA; DINOWITZ M TRANSFER OF DELAYED-HYPERSENSITIVITY IN MICE TO MICROBIAL ANTIGENS WITH DIALYZABLE TRANSFER-FACTOR

1977 INFECTION AND IMMUNITY 16(3):920-922 RIFKIND D; FREY JA; DINOWITZ M SUSCEPTIBILITY OF MURINE TRANSFER-FACTOR TO DIMERIZED RIBONUCLEASE-A

1977 INFECTION AND IMMUNITY 18(1):73-77 SIMON MR; SILVA J; FREIER D; BRUNER J; WILLIAMS R TUBERCULIN-SPECIFIC TRANSFER-FACTOR IN DOGS

1977 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 54(3):269-280 MULLER MR; GROB PJ; HITZIG WH BIOLOGIC ACTIVITY OF TRANSFER-FACTOR TESTED INVITRO WITH CORD BLOOD-LYMPHOCYTES

1977 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 55(1-6):148-151 WYBRAN J; GOVAERTS A; FUDENBERG H DIFFERENTIAL EFFECT OF VINBLASTINE AND COLCHICINE ON HUMAN ACTIVE AND TOTAL T ROSETTES

1977 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 45(3):281-291 HASTINGS RC TRANSFER-FACTOR AS A PROBE OF IMMUNE DEFECT IN LEPROMATOUS LEPROSY

1977 IRISH JOURNAL OF MEDICAL SCIENCE 146(6):167-174 HASSETT AM; WOODS RJ; TEMPERLEY IJ; MULLINS GM CELL-MEDIATED IMMUNITY TO RECALL ANTIGENS INVIVO AND INVITRO

1977 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 238(8):869-871 WOLF RE; FUDENBERG HH; WELCH TM; SPITLER LE; ZIFF M TREATMENT OF BECHCETS SYNDROME WITH TRANSFER-FACTOR

1977 JOURNAL OF IMMUNOLOGICAL METHODS 16(2):119-129 LAWTON JWM; DARG C; PEPPER D; KAY AB HUMAN TRANSFER-FACTOR PREPARED BY DIALYSIS, ULTRAFILTRATION AND GEL CHROMATOGRAPHY - BIOLOGICAL-ACTIVITY IN LOCAL TRANSFER OF SKIN SENSITIVITY

1977 JOURNAL OF IMMUNOLOGICAL METHODS 18(3-4):321-336 SHANNON EJ; HASTINGS RC METHODS FOR IDENTIFICATION OF HUMAN B LYMPHOCYTES

1977 JOURNAL OF IMMUNOLOGY 118(1):62-66 FELSBURG PJ; EDELMAN R ACTIVE E-ROSETTE TEST - SENSITIVE INVITRO CORRELATE FOR HUMAN DELAYED-TYPE HYPERSENSITIVITY

1977 JOURNAL OF IMMUNOLOGY 118(1):88-97 LEE SC; LUCAS ZJ REGULATORY FACTORS PRODUCED BY LYMPHOCYTES .2. INHIBITION OF CELLULAR DNA-SYNTHESIS ASSOCIATED WITH A FACTOR INHIBITING DNA- POLYMERASE ALPHA-ACTIVITY

1977 JOURNAL OF IMMUNOLOGY 118(1):193-197 TANIGUCHI N; MIYAWAKI T; MORIYA N; NAGAOKI T; KATO E; OKUDA N MITOGENIC RESPONSIVENESS AND MONOCYTE-LYMPHOCYTE INTERACTION OF EARLY AND LATE ROSETTE-FORMING CELL-POPULATIONS OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES

1977 JOURNAL OF IMMUNOLOGY 118(2):636-641 VANDENBARK AA; BURGER DR; DREYER DI; DAVES GD; VETTO RM HUMAN TRANSFER-FACTOR - FRACTIONATION BY ELECTROFOCUSING AND HIGH-PRESSURE, REVERSE PHASE CHROMATOGRAPHY

1977 JOURNAL OF IMMUNOLOGY 118(5):1672-1676 HOLZMAN RS; LAWRENCE HS INVITRO AUGMENTATION OF LYMPHOCYTE SHEEP CELL ROSETTE FORMATION BY LEUKOCYTE DIALYSATES

1977 JOURNAL OF IMMUNOLOGY 118(6):1936-1943 GREEN JA; WILLIAMS J; LEVY HB SPECIFIC RESTORATION OF DELAYED-HYPERSENSITIVITY BY LYMPHOID- TISSUE EXTRACTS

1977 JOURNAL OF IMMUNOLOGY 118(6):1944-1950 DUNNICK WA; BACH FH SPECIFICITY AND STRUCTURAL-ANALYSIS OF A GUINEA-PIG TRANSFER FACTOR-LIKE ACTIVITY

1977 JOURNAL OF INVESTIGATIVE DERMATOLOGY 68(1):10-15 HORSMANHEIMO M; KROHN K; VIROLAINEN M CLINICAL-STUDY OF A PATIENT WITH LUPUS VULGARIS BEFORE AND AFTER INJECTION OF DIALYZABLE TRANSFER-FACTOR

1977 JOURNAL OF MEDICAL VIROLOGY 1(3):209-217 MAZAHERI MR; HAMBLIN AS; ZUCKERMAN AJ IMMUNOTHERAPY OF VIRAL-INFECTIONS WITH TRANSFER-FACTOR

1977 JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION 170(2):167-175 ARDANS AA; TROMMERSHAUSENSMITH A; OSBURN BI; MAYHEW IG; TREES C; PARK MI; SAWYER M; STABENFELDT GH IMMUNOTHERAPY IN 2 FOALS WITH COMBINED IMMUNODEFICIENCY, RESULTING IN GRAFT VERSUS HOST-REACTION

1977 JOURNAL OF THE NATIONAL CANCER INSTITUTE 58(4):905-911 DEHORATIUS RJ; HOSEA JM; VANEPPS DE; REED WP; EDWARDS WS; WILLIAMS RC IMMUNOLOGICAL FUNCTION IN HUMANS BEFORE AND AFTER HYPERTHERMIA AND CHEMOTHERAPY FOR DISSEMINATED MALIGNANCY

1977 JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY 21(4):225-230 PLUM J; RINGOIR S LACTATE-DEHYDROGENASE ISOENZYME PATTERN AS A MEASURE OF CELLULAR DIFFERENTIATION IN LYMPHOCYTIC CELLS

1977 JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY 21(6):403-416 GOTTLIEB AA; SAITO K; SUTCLIFFE S; FOSTER LA; TAMAKI N; MAZIARZ G; SUTHERLAND C; BRENNESSEL B BIOCHEMICAL-ANALYSIS OF DIALYZABLE LEUKOCYTE EXTRACTS

1977 JOURNAL OF UROLOGY 117(5):553-556 MONTIE JE; BUKOWSKI RM; DEODHAR SD; HEWLETT JS; STEWART BH; STRAFFON RA IMMUNOTHERAPY OF DISSEMINATED RENAL CELL-CARCINOMA WITH TRANSFER-FACTOR

1977 KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE 171(1):63-70 ROCHA H TRANSFER-FACTOR IN OPHTHALMOLOGY

1977 LANCET 1(8004):198-199 BOUCHEIX C; PHILLIPS J; PIZZA G; SARTORIO C; VIZA D ACTIVITY OF ANIMAL TRANSFER-FACTOR IN MAN

1977 MEDICAL JOURNAL OF AUSTRALIA 2(19):621-622 NELSON DS IMMUNOTHERAPY IN MALIGNANT DISEASE

1977 MINERVA PEDIATRICA 29(10):651-655 BALSAMO V; BRAI M; MOGAVERO S; TOLONE G; LAGRUTTA A PRELIMINARY EXPERIENCES IN TREATING WISKOTT-ALDRICH SYNDROME WITH TRANSFER-FACTOR

1977 MOUNT SINAI JOURNAL OF MEDICINE 44(6):752-760 HORSMANHEIMO M; FUDENBERG HH MEDIATORS OF DELAYED-HYPERSENSITIVITY REACTION IN SARCOIDOSIS

1977 NEW ZEALAND MEDICAL JOURNAL 85(579):3-6 SUTHERLAND DC; WILSON JD; DOUGLAS R TRANSFER-FACTOR THERAPY - CLINICAL EXPERIENCE AND ROLE OF E- ROSETTE ASSAY

1977 PEDIATRIC CLINICS OF NORTH AMERICA 24(2):293-311 AMMANN AJ T-CELL AND T-B CELL IMMUNODEFICIENCY DISORDERS

1977 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 156(2):247-250 TOMAR RH; TERZIAN J REACTIONS IN CANINE SKIN WITH HUMAN LEUKOCYTE LYSATES

1977 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 6(1-2):15-30 PERSSON U; COUTINHO A; MOLLER G REGULATION OF INVITRO IMMUNOCYTE ACTIVATION - ORIGIN OF AND TARGETS FOR CELL-RELEASED INHIBITORS

1977 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 6(11):1101-1106 SHARMA MK; ANARAKI F; ALA F SPECIFICITY OF TRANSFER-FACTOR - INVITRO LYMPHOBLAST TRANSFORMATION OF PERIPHERAL LYMPHOCYTES TO LEISHMANIA MAJOR ANTIGEN IN PRESENCE OF TRANSFER-FACTOR

1977 SCOTTISH MEDICAL JOURNAL 22(4):320-330 ROBERTS JA IMMUNOTHERAPY IN TREATMENT OF CANCER

1977 SOUTHERN MEDICAL JOURNAL 70(2):230-235 HILL HR EVALUATING PATIENT WITH RECURRENT INFECTIONS

1977 TEXAS REPORTS ON BIOLOGY AND MEDICINE 35():375-380 GIFFORD GE; TOBEY M EFFECT OF INTERFERON AND LYMPHOKINES ON LYMPHOCYTES

1977 TRANSACTIONS OF THE OPHTHALMOLOGICAL SOCIETIES OF THE UNITED KINGDOM 97(APR):8-17 EASTY D MANIFESTATIONS OF IMMUNODEFICIENCY DISEASES IN OPHTHALMOLOGY

1977 TRANSPLANTATION PROCEEDINGS 9(1):1319-1326 LAWRENCE HS TRANSFER-FACTOR IN TRANSPLANTATION IMMUNOBIOLOGY

1977 VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY 374(2):87-103 HEYMER B; NIETHAMMER D; SPANEL R; GALLE J; KLEIHAUER E; HAFERKAMP O PATHOMORPHOLOGY OF HUMORAL, CELLULAR AND COMBINED PRIMARY IMMUNODEFICIENCIES

1977 WESTERN JOURNAL OF MEDICINE 126(1):14-31 WING EJ; REMINGTON JS CELL-MEDIATED-IMMUNITY AND ITS ROLE IN RESISTANCE TO INFECTION

1977 WESTERN JOURNAL OF MEDICINE 126(2):102-109 HOLMES EC; MORTON DL; EILBER FR IMMUNOTHERAPY OF CANCER

1977 WIENER KLINISCHE WOCHENSCHRIFT 89(10):333-336 KOHOUT J PASSIVE TRANSFER OF TUBERCULIN SENSITIVITY

1977 ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY 153(5):380-394 WENZEL B; AVERDUNK R DIFFERENTIATION BETWEEN VARIOUS EFFECTS OF CYTOTOXIC FRACTIONS OF LYMPHOCYTE CULTURE MEDIUM

1977 ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII (7):28-33 GUDKOVA EI; SAKHAROV PP IMMUNOLOGICAL MECHANISMS IN ORGANISM OF PATIENTS SUFFERING FROM INFECTIOUS ALLERGY IN DESENSITIZING THERAPY

External links

• Transfer+factor at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
• Template:EMedicineDictionary
• Drug Information Online
• Books About Transfer Factor
• [1]